incivo works by stopping the virus that causes hepatitis c infection from multiplying . incivo is used to treat adults with chronic hepatitis c in patients who are 65 years of age and older . it is used in combination with peginterferon alfa , ribavirin and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the ns3 + 4a enzyme inhibitor stops hepatitis c virus from multiplying and infecting other cells . it can also be used in patients whose previous treatment with peinterferone alfa and ribavir did not work well enough . incov is used for
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking peginterferon alfa or ribavirin . if you think any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking incivo . peginerferonalfa and ribavir are not recommended for use in combination with incivo , and are therefore not recommended to be taken together with inciv . if any of you are taking any of any of , or have recently taken any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage always take the appropriate dose regimen exactly as described in this leaflet . you should check with the doctor or nurse if you have not been trained . the recommended dose regimen is 3 mg twice a day ( 6 mg twice daily ) taken in combination with 2 mg twice weekly ( 8 mg twice per day ). your doctor will tell you the dose that is right for you . the dose may need to be adjusted by your doctor if you suffer from both hepatitis c virus infection and human immunodeficiency virus infection
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : if you get an itchy skin rash , stop using incivo and seek medical help immediately . the rash may be severe . other symptoms of a severe skin reaction tell your doctor immediately if you have a skin rash . your doctor may decide to treat your rash with other medicines . other signs of a rash include : fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash with peeling skin , fever , flu - like symptoms , painful skin blisters or blisters in the mouth , eyes ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo releases 375 mg telapvir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
zinbryta contains the active substance daclizumab beta , a monoclonal antibody . what zinbryt is used for zinibryta is used to treat multiple sclerosis in adults . it is used together with therapy ( two ms treatment courses ) or with other treatments to reduce inflammation ( the protective sheath around the nerves in the central nervous system and the brain and spinal cord ). this loss of myelin ( a substance that helps to coordinate movement ) is called demyelination . relapsing ms can lead to repeated attacks ( relapses ). symptoms occur when the nerves around the brain
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from liver problems . warnings and precautions talk to your doctor or pharmacist before taking zinibryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . take special care with zinabryta tell your physician if you take , have recently taken or might take any other medicines . herbal supplements tell your pharmacist if you or your child are taking any
your doctor will decide how much zinbryta you need and how often you need to take it . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of zinba is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . your dose of the first dose of your first dose is 40 mg once daily . your next dose may be higher . your second dose may need to be higher or lower . your third dose may require a blood sample to check your liver
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems ( very common : may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : may affects up to 1 in 100 people severe inflammation of the liver may lead to death . tell your liver doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . before you start using a new syringe / pen , use a refrigerator to record the date when zinba / pens are first removed from the refrigerator . zinbarryta syringes /
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solution contains sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zinabryta contain sodium '). what zinbaryta looks like and contents of the pack zin bryta is a clear to slightly yellow solution for injecting into a syringe / pen . it is supplied in
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion , which affects the liver , eyes and brain . this can lead to liver damage and neurological disorders . wilzin works by attaching to copper in the intestine and its further accumulation in the body . wilston ' s diseases has been associated with the development of certain types of liver damage , neurological disorders , and with the build - up of copper in large amounts in the large intestine and for its further accumulation in the organ . the development and spread of wilson ', s disease has been linked
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin . warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults who have signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . wilzin should be used during the initial treatment in combination with other anti - copper agents . penicillinamine may improve your symptoms and your response to the treatment . your doctor will monitor your blood and urine regularly to ensure that
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are available in the following strengths : 25 mg and 50 mg : 1 capsule of wilzin 50 mg in the morning and 2 capsules of wilzan 25 mg in 1 capsule . 1 capsule with wilzin 25 mg : 50 mg and 2 capsule of the wilzin 75 mg in a morning and 1 capsule in a evening . 1 to 6 capsules of the medicine each day . your doctor will tell you how many capsules to take . the usual dose is one capsule of one capsule each day
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ), not known ( frequency cannot be estimated from the available data ) very rare ( affecting less than1 user in 100 ), not available ( frequency not known ) very common : may affect more than1 in 10 users very rare : may affects lessthan 1 user of 10 ,000 not known
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule also contains 50 mg of the active substances ( equivalent of 167 . 84 mg of of zncp ) zinc acetates dihydrated . the other ingredients are magnesium stearate and water for injections . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e133 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , ob
biktarvy contains the active substances bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor ( rtrti ) emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ), tenofovir alafenamide , an antiiretviral medicine named a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) in adults . it is used to reduce the risk of infection with
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , tell your doctor . if you have recently taken any of any of your following medicines : - rifampicin ( used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ), a herbal remedy used to help prevent depression and anxiety ) warnings and precautions talk to your doctor before taking bik
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your diet should be taken in combination with aluminium and magnesium hydroxide mineral supplements . your daily dose should be equally distributed between vitamins such as magnesium and iron . see section 2 " taking these medicines with biktarvy " for further information . if you take more biktorvy than you should
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : inflammation or infection in patients with advanced hiv infection ( aids ) or opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , which helps fight infections . there are no obvious symptoms of autoimmune disorders , which occur when the immune system attacks healthy body tissue . medicines given to treat hiv infected patients may cause autoimmune disorders many months after treatment .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each bikttarvy tablet contains bic tegravira sodium equivalent to 50 mg bicchegravirin , 200 mg emtrititabin , tenofovegal alafeneamide fumarate equivalent to 25 mg tenofoviir alufenamide ). the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium
novarorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2abetes in adults . treatment is usually started with diet and exercise and weight reduction . your blood pressure may be lowered when novonor is taken in combination with metformin . if you have diabetes , novonors may not control the
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . the acid level in your blood may increase ( diabetic ketoacidosis ). if you suffer from a severe liver disease . if your doctor has told you that you are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 if you know that you have liver problems . novonors should not be used if you think you have moderate liver disease , as novonere may not be suitable for you . if any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the maximum recommended dose for adults is 30 mg once daily for 4 weeks . your doctor may increase your dose to 30 mg twice daily for 16 weeks . if you take more novonor than you should if you accidentally take too many tablets , contact your doctor . if possible , show them the pack . if your blood sugar is too high ,
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of novonorm is hypoglycasemia ( common may affect up to 1 in 10 people ). if you have a hypo in section 2 , you should contact your doctor immediately . hypoemic reactions are generally mild / moderate . however , hypoglycemic unconsciousness may lead to coma . allergy allergy ( rare may affect upto 1 in every 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), iron oxide red ( e 172 ) and water for injections ( see section 2 " novonors contains lactose "). what novonor looks like and contents of the pack novonom tablets are white to off - white , round , flat
pumarix is a vaccine used to protect adults ( aged 18 years and older ) against pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . pandemicflu is similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients that may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if this happens , the vaccine should not be given and you should immediately go to the nearest hospital for medical treatment . an allergic response to any ingredients of pumarip may occur . if any of
pumarix is intended for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 vaccine . pumix is used in children aged 3 - 9 years and adolescents aged 10 - 17 years . how pumarux is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and need emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where thejection is given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where the injections are given bruising a hard lump , itching
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the suspension after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after preparation of the vaccine , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 30 . do away with pumarix if you notice any particles in the suspension . do throw away any
what pumarix contains the active substance is split influenza virus ( a / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which are used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - Î± - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water for injections . what pumarax looks like
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . when used in combination with gallium (' 68ga ') edotreaotide , this procedure allows the doctor to obtain more information about the amount of gallium ' in the blood and the amount edotreeotide in the body areas . somakit to is used for a medical imaging procedure called positron emission tomography ( pemphigus ) in adults and pet - positive patients . this medical procedure is to obtain images of the abnormal
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking somakttoc if any of these apply to you . you must tell your doctor if you have had allergic reaction to any of those ingredients ( listed under section 4 ) before taking this medicine . if you suffer from kidney or liver problems . if your doctor has told you that you have renal or hepatic disease . children and adolescents do not give this medicine to children and teenagers under 18 years of age because of the
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . they will keep you informed of their actions and will keep your appointments . they are responsible for the correct storage of somakttoc 29 during and after the procedure . the quantity of somackittoc that will be administered depends on the individual individual individual needs . the usual dose is 100 to 200 megabecquerel per kilogram of body weight . the administration of somaksittoc should be supervised by a
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) that have been reported after administration of somakit to patients with symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . the site of the injection may be exposed to low amounts of ionising radiation ( which may increase the risk of cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be done in accordancewith national regulation . somakit t will be stored at a concentration of 4 to 25 mbq / m2 . do not use somakito if you notice any visible signs of deterioration . radioactive products should be disposed of in accordance accordance with local requirements .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotereotide . - the other ingredients are 10 - phenanthroline , gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . - in the solvent , the solution contains hydrochloric acid . what somakiton t looks like and contents of the pack somakt t is presented as a radiopharmaceutical preparation . it is supplied as a glass vial with black flip - off cap
afinitor is an anticancer medicine that contains the active substance everolimus . everolim slows the growth and spread of cancer cells . afinitor acts by blocking the activity of a hormone receptor called hormone receptor - positive advanced breast cancer ( postmenopausal women ) that is resistant to non - steroidal aromatase inhibitors ( a group of medicines that keep the disease under control ). afinit is used in combination with a medicine called exemestane ( a steroid oedema inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours that affect the stomach , bowels
do not take afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before taking afinit . do not take any of the following : if you have everolimus , sirolimus or temsirolimo in combination with this medicine . if you think you may be allergic , ask your doctor for advice . warnings , precautions and precautions tell your doctor before taking any afininitor : if any problems with your liver . if any disease affects your liver , your doctor may prescribe a different dose of afincer . if your doctor has diabetes or a high level of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg taken twice a day . if you take more afinitor than you should if you have liver problems , your doctor may prescribe a lower dose of afincer . the usual dose is 5 mg once a day , but your doctor will adjust your dose to 5 mg or 7 . 5 mg if you experience certain side effects . if any of these apply to you , tell your doctor . if possible , your dose may be reduced or you may stop taking afin
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience an allergic reaction including : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps . other side effects with afincer include : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the lung ( pneumonitis 46 common ( might affect up to 1 in every 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this by gently squeezing the tablet until it is completely dissolved . open the blister and take the tablets at the same time each day . donot use this medication if you notice any visible sign of tampering . do so immediately , even if the tablet is still fully opaque . do no more than once a day , unless your doctor tells you to . do away with the blister .
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet contains 5 mg of Everolimus in each tablet . afincitor 10 mg tablet : each tablets contains 10 mg of of everlimus in one tablet . the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactase anhydrous . what afinitors looks like and contents of the pack af
what laventair ellipta is the active substance of lavent air ellipta consists of two active substances called umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laventAir ellipta looks like and contents of the pack lavent Air ellipta comes as a low - dose inhalation for adults . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur when copd attacks the muscles around the airways . this medicine prevents tightening of these
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : - if your child has asthma . warnings and precaution talk to the doctor or nurse before using lavent air ellipta : - tell your doctor if your baby has asthma , heart problems , high blood pressure , or an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ).
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . try to use it at the right time each morning and evening . it is important that you use lavantair ellipte every day until your doctor tells you otherwise . if you have symptoms of lavent air ellipta such as a sudden attack of breathlessness or wheezing , stop using the inhaler and seek medical advice
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop taking laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : ( may affects up to1 in 1 , 000 people ): swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ). immediate breathing
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umechinium , 65 microgramms umecylidinIUM bromides and 22 microgramrams vilancerol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose '), magnesium stearate . what laventAir ellipta looks like and contents of the pack laventAIR ellipta is an inhalation powder . the ellipt
tovya contains guselkumab , a monoclonal antibody . this medicine contains the active substance " il - 23 ". this belongs to a group of proteins called cytokines , and is used to treat psoriasis in adults with moderate to severe " plaque psor psorism ". plaque psoreiasis is an inflammatory condition that affects the skin and nails . tremfya works to improve the condition on the skin , and to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and risks talk to the doctor or nurse before using or using tremfaya if : you have ever had an infection or an infection with tuberculosis . you have tuberculosis or have been in close contact with someone who has had tuberculosis 36 you have or have ever been in contact with somebody who
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 micrograms solution for injection ( 1 pre - filled syringe ) is given under the skin ( subcutaneous injection ) every 4 to 8 weeks . your doctor will decide how many treatments you need . your healthcare professional will show you how to inject tremffa . if you use more tremfyna than you should tremfia should be injected under the control of a healthcare professional . if tremfja is not used immediately , treatment should be stopped immediately . symptoms of psor
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not inject this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what tremfYA looks like and contents of the pack solution for injection in tremfia is a clear , colourless solution . tremfyna is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 pack of single - set pre
the active substance of trepulmix is treprostinil . treprosticinil belongs to a group of medicines called prostacyclins , a hormone that helps to raise blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ), in adult patients who have persistent or recurrent ctph and whose medical , surgical treatment and exercise capacity have not helped to reduce symptoms of the disease . chronic throbboembolmonary hypertension ( pth ) is a condition in which
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if your baby has a heart problem . - your baby may have had a heart attack ( myocardial infarction ) within the last six months .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is intended for a continuous subcutaneous infusion under the skin , using a small tube ( cannula ) that goes into the abdomen or thigh . trepanmix is supplied in a pouch or a portable pump . you can take your treprostinil with or without food . the pump is connected to the infusion line to help prevent accidental overdose . the recommended dose is 1 mg / kg , 2 . 5 mg / 5 mg or 10 mg / ml . infusion rate the infusion
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in every 10 people ) dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ), swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and / or legs 36 uncommon ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do away with the vials . trepulmix may be used if it is accidentally frozen for a single period of less than 30 days . for continuous subcutaneous infusion , it should be used in a single reservoir ( syringe ) of undil
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial of 10 ml contains 10 mg trepristinila ( as water for injections ). each 20 ml vials of trepulamix 2 . 5 mg : one vial containing 2 . 25 mg trepistinIL ( as salt ). one 10 ml ampoule of 25 ml contains 25 mg of treprosticinil ( ( as natural gas ). one 50 ml ampule of trepiost
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enalaparin . it works in two ways : 1 ) to prevent existing blood clots from forming . 2 ) to stop blood clubs from forming in your blood . thorinne is used to prevent blood clumps from forming within your blood during or after an operation . it can be used : - if you have an acute illness called unstable angina ( unstable angine ) - if your heart is working normally ( normal ) but you have
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using thorinan : - if your doctor has told you that you are at an increased risk of having an allergic response to other low molecular weight heparins ( e . g . nadroparin , tinzap
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding . tell your doctor immediately if you experience any bleeding event that does not stop . excessive bleeding may be accompanied by exceptional weakness , tiredness , paleness , dizziness , headache , or unexplained swelling . tell the doctor immediately , or stop your medicine . if you have had a severe allergic reaction , including difficulty breathing , swelling of the lips , mouth , throat or eyes , or blockage of a blood vessel ( a blood clot ). if you develop cramping pain , redness , warmth , swelling , especially of the legs ( symptoms of deep
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe label after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 0 . 2 ml of enoxapearin sodium and is for single use only . after dilution , each ml contains 2 , 000 mg of enxaparinodium and is used for injections . the final dose is 0 .2 ml . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger rod . it is available
sensend contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which may help to prevent ejaculation .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions sensitivity to local anaesthetics if you have been treated with amide - type local anahetics , you should tell your doctor if you suffer from a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ), anaemia ( methaemoglobinaemia ). medicine sensitivities and sensitivity to sunlight if you know you have severe liver problems , stop
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per day ) taken by mouth . 1 spray in the head of your penis . 3 sprasters per day . 24 sprays per day , for 4 weeks . how to use use the spray container and the pump mechanism . avoid contact with eyes , nose , mouth and ears . how long to use - the pump is only for use in adults . - 1 spray into the foreskin of your head of the penis .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ): inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ): headache local irritation of the throat , irritation of or irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the part of your penis pain or discomfort in the pris itching in the place of your erection a high temperature . other side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer after this period . donot puncture or burn the container . do this if you notice any particles in it . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilacaine . one spray container contains 50 ml of lidocane and 7 . 5 ml of prilucaine . - each spray container provides 2 . 5 mg of prlocaine per ml . - the other ingredients are water for injections . what senstends looks like and contents of the pack senstEND is a clear , colourless to light yellow cutaneous spray . each spraycontainer contains 6 . 5 to 20 ml of clear , clear ,
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma that has not responded to complete resection in adults ( treatment , including surgery or adjuvant therapy ) advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma if previous therapies have not worked or have not been tolerated or have failed to work or have been given an autologous stem - cell transplant ( a transplant ). advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) the
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opdivov if you : - have problems with your heart ( a change in the rhythm or the heartbeat ) - have an abnormal heart rhythm - have any problems with any of your lungs ( breathing difficulties or cough ) - inflammation of the lungs ( pneumonitis or interstitial lung disease ) - diarrhoea , watery , loose or soft stools - have or have had any symptoms of inflammation of any intestines ( col
always take opdivo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much opdivose to take the recommended dose of opdivoe is 240 mg given as 2 tablets once a day ( corresponding to 480 mg per 4 kilogram of your body weight ). the recommended doses of opDivo are ipilimumab and the treatment of skin cancer . the recommended dosage of op divo is 1 tablet of nivolumab per kilogram ( kg ) of your person weight . the dose is 4 tablets once daily ( correspondingto 240 mg per 2 or 480
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and transport refrigerated ( 2 - 8 ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at refrigerated temperature . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of niviolumab ( as 40 mg / ml ). each vial contains 4 ml of solution for injection ( 100 mg / 10 ml ). the vial may contain 240 mg / 24 ml of nvelolumb . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events (
do not take clopidogrel tad 30 - if you are allergic to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). - if a medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrel tetad . warnings and precautions if any situation you are at risk of bleeding suchas - a medicalcondition that puts you at risk for internal bleeding ( such as : - a stomach urcer ) - a blood disorder
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl tad ( 4 tablets of 75 mg ) once at the start of treatment . then
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopipidogl . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopridogrel tetad looks like and contents
tacrolimus contains the active substance tacrolimos . tacforius is an immunosuppressant . it is used after your organ transplant ( liver and kidney ) to reduce the response of your body ' s immune system . tacfortius can be used alone or with other methods of preventing your body rejecting the transplanted organ . tacfius is used to prevent rejection of transplanted organs by patients who have already received liver and kidneys and heart , or who have received any previous treatment after your transplantation .
do not take tacforius - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to sirolimus , to any macrolide ( antibiotic ), to erythromycin , clarithromycin or josamycin . warnings and precautions tacforia immediate release capsules ( e . g . tacrolin ) are not interchangeable with tacforix prolonged - release capsules . tacrulimus prolonged -release capsules are not compatible with tacrolamus prolonged release capsules and should be taken together with tacfil
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . your doctor will prescribe the same tacrolimus medicine for you . if you have had a transplant before , your doctor may prescribe a different tacroleus medicine . always take this medication exactly as described in this leaflet . check each box to make sure that you have the right medicine . the rejection of your transplanted organ will be caused by your body weight . the usual starting dose for transplantation is 0 .
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and seek medical attention immediately if you notice any of the following serious or severe effects : allergic and anaphylactic reactions ( benign or malignant tumours ) have been reported during tacforia treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ) and agranulocytosis ( a severely lowered number of white blood cells ) have also been reported . haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . discard 1 capsule after opening the aluminium wrapping . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg : each capsule contains 0 . 25 mg tacrolamus ( as monohydrate ). tacforia 1 mg : one capsule contains 1 mg tacrulimus ( monohydrate ) . tacfius 3 mg : three capsules contain 3 mg taclimus (" monohydrate "). tacforiu 5 mg: one capsule contain 5 mg tacrimus ( ( asmonohydrate ). the other ingredients are capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . capsule shell
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , do not take the next dose of clopridogrelzentiva . warnings and precautions if any situation you are at risk of bleeding suchas : - a medicalcondition that puts you at risk for internal bleeding ( such
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep clopidogrel zentiva in aluminium blisters in order to protect from light . do away with clopridogrel zinc if you notice any visible sign of deterioration . do so immediately after opening the blister . donot throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopigrel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopiderel zenta contains lactose ' and ' clogidogl zentive contains hydrogenated castor oil '): tablet core : mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e
yttriga is a radioactive medicine that is stored in a refrigerator ( 2 - 8 ). it is stored at room temperature ( up to 25 ). it must not be used if it is accidentally frozen . yttrigba is stored next to another medicine that has been prepared in tiny radiation doses . the treatment is a radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you must not become pregnant if you think you may be pregnant . - if any of these apply to you , tell your doctor before you are given ytriga . - yttrada is a radioactive medicine . - it is not used as another medicinal product . - radiopharmaceuticals are not to be disposed of via wastewater or household waste . - the use of ytiga in the processing of radioactive material is not recommended . - radioactive medicinal products
the treatment should be supervised by a doctor experienced in the diagnosis and treatment of medicinal products . method of administration yttriga is for radiolabelling of medicinal product for specific diseases . yttiga should be administered immediately after preparation . if you are given more yttrada than you should in the event of overdose , your doctor will provide appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises and local regulations . storage of radioactive substances will be in accordance with national regulation on radioactive materials .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttrada looks like and contents of the pack yttiga is a clear , colourless type i glass vial with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , which is used as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , which has not responded to prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine the appropriate dose of ciamba depending on the type of lungcancer you have and on the severity of your disease . treatment with initial chemotherapy ciamra is a treatment
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb . warnings and precautions talk to your doctor , pharmacist or nurse before using ciamBra . children and adolescents ciamba is not recommended for use in children and young children aged 6 months and above . breast - feeding should be stopped during treatment with ciambre . if you have recently received or are about to receive a vaccine against yellow fever , tell your doctor before using this medicine . ciamra should not be used if you currently have or have ever had problems with your
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area based on your weight and height and will adjust your dose , depending on your response to treatment and on your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your veins . the infusion will last
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38Âºc or greater sweating ( common ). infection ( uncommon ) if you have less white blood cells than normal which may be a sign of infection ( sepsis ) which may lead to death . if you get chest pain ( common ), with a fast heart rate , pain , redness , swelling or sores in your mouth ( very common ). allergic reaction ( uncommon ). if you develop skin rash ( common , may include burning or prickling sensation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expirability of the infusion solution of pemetrexed is 24 hours at 2 - 8 and 15 to 25 . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours between 2 -8 and 15 - 25 . if the reconvituted product is not used promptly , in use immediately .
what ciambra contains the active substance is pemetrexed . each vial of ciamba 100 mg contains 100 mg of pemetreed ( as pemetretrexed disodium hemipentahydrate ). each vials of cimbra 500 mg contains 500 mg of the active ingredient pemetresed (as pemetretted dis sodium hemipontahydrated ). after reconstitution , the solution contains 25 mg / ml of pemrexed without further dilution . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ), sodium hyd
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam helps to control certain infections in your blood . immunogom may be used to prevent increased levels of human hepatitis b immunoglubulins and immunoglofulin g ( gg ) in blood plasma of healthy adults . immunoglogam is used to treat hepatitis b virus in haemodialysed patients . vaccination is a process in which a hepatitis birus carrier ( the b virus ) develops an immune response that produces measurable hepatitis b antibodies . vaccination and continuous prevention are available for individuals who are infected by
immunogam should not be given if you have an allergic reaction to human immunoglobulins or other blood products . if you suffer from an iga deficiency , an allergic response may occur to iga containing products . children and adolescents ( aged 18 years and above ) immunogloglobulin are not recommended for use in children and teenagers below 18 years of age . in some cases , allergic reactions such as chills , headache , fever and vomiting have been reported . in rare cases , serious allergic reactions ( such as nausea , arthralgia ), joint pain , low blood pressure and moderate low back pain have
immunogam is intended for vaccination of hepatitis b virus . the first vaccine dose will be given in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose of hepatitis c is 500 micrograms given every 24 hours for 72 days . the recommended recommended dose for hepatitis b in haemodialysed patients is 500 mbq given every 2 weeks . seroconversion is the first step in vaccination of patients with hepatitis b , as a hepatitis birus carrier . the hepatitis b antigen should be prepared in accordance with the recommendations of the hepatitis c immunoglubulin administration and ser
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported with immunogams : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). not known ( frequency cannot be estimated from the available data ) undesirable effects have occurred during clinical trials with immunoglobulin . the injection site is usually a muscle . common ( affect 1 to 1 user of 10 ,000 ) very common : 7 nausea
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunongam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one ml of immunogaman contains 1 to 5 mg of human plasma protein ( antigen ) 96 per ml . - the other ingredients are polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution for injection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunoglubulin .
remicade contains the active substance infliximab . infliximumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnf ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis remicades is used in adults , adolescents and children aged 6 years and older . these include crohn
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these ingredients if you have tuberculosis ( tb ) if your doctor thinks you may have another serious infection such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take remicitade more than once a day , contact your doctor . if any of this applies to you , tell your doctor before taking remicADE . if your dose of remicitades
the usual dose for adults with rheumatoid arthritis is 3 mg per kilogram of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the usual dose is 5 mg per kg of bodyweight . how remicade is given remicine will be given to you by your doctor or nurse . how it is given the medicine will be administered as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be started with
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects . your doctor may decide to stop treatment if you notice any of the following side effects during or after your treatment with remicade : - an allergic reaction : - swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild to severe and usually disappear within a few days . an allergic allergic reaction may occur within 2 hours
keep this medicine out of the sight and reach of children . do not use remicade after the expiry date which is stated on the carton and vial after exp . the expirability of this medicine is stated in the following order : store in a refrigerator ( 2 8 ). do not freeze . store in the original package in order to protect from light . do away with remicades if it is accidentally frozen . infusion - related storage : 3 months storage at 2 8 for up to 28 days . if you are not able to take remicad for a single period of up to 24 hours , it must be
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixumab . after preparation each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicada is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicad is available in packs containing 1 , 2 , 3 , 4 or 5 vials .
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson's disease ). with parkinson ', s disease causes a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body involved in movement control . rasagilinea mylan increases the amount of dopamine produced by the brain and helps to control movement .
do not take rasagiline mylan - if you are allergic to rasabiline or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan ( monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease ) medicinal or natural products ( e . g . st . john ' s wort ) pethidine , a strong pain killer . children and adolescents rasaggiline melan is not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at the same time each day . swallow the tablet whole with a glass of water . you can take rascagilrine mylan with or without food . if you take more rasgiline than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the rasvagiline melan carton . if someone else accidentally takes your tablets , tell
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects reported when rasagiline mylan was given in combination with placebo have been reported with frequency not known ( cannot be estimated from the available data ). the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 1 users in 1 , 000 ) very rare ( affects less than 1 users per 10 , 000 ). very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) feeling of
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasgiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize ), talc , stearic acid . what rasvagilinemylan looks like and contents of the pack rasigiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the
do not use hulio : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , such as tuberculosis . check with your doctor if your baby has symptoms of infections , suchas fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . if your newborn has a serious heart condition . warnings and precautions allergic reaction allergic reactions may occur with symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . tell your doctor immediately if your infant has
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults and adolescents from 2 to 17 years old weighing 10 kg or more : one 30 mg tablet of hulio 20 mg / 2 ml solution for injection in children from 2 - 17 years of age weighing 30 kg or less : one 40 mg tabletof hullio 40 mg / 1 ml solution in children with enthesitis - related arthritis in children 6 to 17 months of age weighed 15 kg or greater : one 20 mg tablet in children and adolescents
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . tell your doctor straight away if you notice any of the following side effects ( which may occur up to 4 months after the last hulio injection ): allergic reaction including heart failure severe rash or hives swollen face , hands or feet trouble breathing or swallowing pale complexion , dizziness persistent fever , bruising or bleeding . tell a doctor straightaway if you have signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hul io 40 mg solution for injection is a sterile solution containing 40 mg of adalimimumab in 0 . 8 ml solution . the solution is clear to slightly opalescent and colourless to pale yellow . it is supplied in glass vials with a rubber stopper . hullio is available in packs containing
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have asthma or skin allergy ( intense inflammation in your nose ). warnings and precautions talk to your doctor or pharmacist before using yellox . you should not use other nsaids ( e . g . acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine should not be used in combination with topical steroids ( cortisone ) as it may increase the risk of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in each eye ( s ) twice a day . the recommended daily dose is one dose in the morning and one drop of the same eye (s ) twice daily . use in children and adolescents the recommended starting dose is 2 drops in the day before your cataract surgery . method of administration yellox is for oral use . wash your hands thoroughly after using the eye drops . remove the bottle cap from the bottle . hold the bottle ,
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate , sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
duvovo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufantanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . swallow the tablet whole with a glass of water . you can take this medication with or without food . dzuveo must be taken with strong painkillers such as sufentanil at least 30 minutes before or after food . the sublingual tablet must be swallowed whole with the disposable single -dose applicator . the applicator should be inserted under the tongue . if the tablets dissolve , the tongue may not be fully controlled . pain
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , slow and shallow breathing . if you get any of these side effects stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) : inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drows
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do this medicine if you notice any visible signs of deterioration . do tell your pharmacist if you are concerned that medicines may not be stored correctly .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine ( e132 ), stearic acid , magnesium stearate . what dzuvello looks like and contents of the pack dzu veo is a white to off - white , round tablets with " d " debossed on one side and " 3 " debottled on the other side
what erleada is erlead is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and cannot be removed by surgical treatments . it also works to treat sensitive prostate cancer which has spread beyond the original body and has not responded to surgical treatment with testosterone . what erlea is used for erleade is used in adult men with resistant prostate cancer . erleADA blocks the action of androgens , which are involved in the growth and spread of the cancer . by blocking the action , androgens like apalutaamide stop
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be pregnant . - if if you could become pregnant ( see pregnancy , contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine should not be taken if you have any of these conditions : - seizures - if any medicines that can cause blood clots ( e . g . warfarin or acenocoumarol ) - if there are any heart or blood vessel conditions that could increase the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how well you respond to erleada . take this leaflet with you . this medicine is taken by mouth . if you take more erleade than you should if you accidentally take too many tablets , contact your doctor immediately . taking other medicines please tell your doctor if you have taken more tablets than you have been told to . if possible , take your tablets with food . erlead
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( dress ) ( dress ). other serious side effects tell your doctor or pharmacist if you notice any of these side effects : fits ( seizure
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine cellulosa . - in addition , the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erlead
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for the scan ( a pet scan ) in adults who have previously had treatment for prostate cancer and have had other tests to check prostate specific antigen ( psa ) ( the type of protein that carries the cancer ). an axumin pet scan may show that the cancer has spread to other parts of the body . the scan will be recorded on the patient alert card . your doctor or nurse will record the results of this procedure on the radiopharma .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for the duration of the axumin scan . this is usually for 4 weeks . during the scan , you will take your usual medicines and take them at least the latest 60 minutes after the axus injection . - urination during the time following the scan
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use this medicine safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . the quantity to be administered depends on the type of medicine being used . administration of axum before the procedure axumin is given into
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) when the medicine was given in combination with another medicine . the following other side effects have been reported when axumin was given alone ( affects 1 to 100 users in 1 , 000 ): pain , rash , altered taste in the mouth , altered sense of smell . this radiopharmaceutical delivers low amounts of ionising radiation which can cause the body to produce more radioactivity than normal , which can be harmful for cancer and hereditary abnormalities . reporting
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : axumin will be stored in a safe place .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( as besilate ). each 16000 mg vial of axumin 3200 mg contains 3200mg of fluiclovin ( as mesilate ) ( as resilate). each 3200 - mg vials of axum 3200 + contain 32000 mg of the active substances . - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what ax
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . the pressure in your eye increases , which in turn , damage your sight .
do not take azopt - if you have severe kidney problems - if your doctor is allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). - if if you are allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may apply to some patients : - if there is too much acidity in your blood ( hyperchloraemic acidosis ). your doctor may need to adjust your dose of azopt if you :
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used for the eyes only . use azopt in both eyes only once a day . use in both eye and eyes only : 1 dose in the morning and 2 doses in the evening . use within 3 hours . do not shake the azopt bottle . wash your hands . remove the cap from the bottle . the cap can be removed with a snap collar . hold the bottle tightly with both hands . tilt your head back . pull down your eyelid with a clean finger until there is a '
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects ( might affect upto 1 in 100 people ) â effects in your eye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , redening
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brin zolamide - the other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide to maintain acidity levels ( ph levels ) and to reduce the acidity . what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw
the active substance of forxiga is dapagliflozin , which belongs to a group of medicines ( medicines taken by mouth ) used to treat diabetes . it works by reducing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ) to treat the following diabetes types : type 1 diabetes : this is a problem that occurs when your body does not make enough insulin . forxigo is used to control this problem in adults . type 1 : this problem occurs when you are overweight or obese . type 2 diabetes : your body is not making enough insulin or the insulin that your
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor immediately if you experience any of any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . forxiga is also available for patients with type 2 diabetes . the usual starting dose is 10 mg once a day . your doctor may increase your dose to 5 mg once daily if you have a liver problem . your dose may be adjusted by your doctor . your treatment with forxigo is also applicable for patients of type 1 diabetes . your starting dose may also be increased to 5mg once a week . taking this medicine swallow the tablet whole with some water . your body may adjust the amount of forx
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( seen very commonly ( may affect more than 1 in 10 , 000 people ). angioeema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen commonly ( might affect up to 1 in every 10 people ) in patients with type 2 diabetes , seen commonly (> 1 in 1 , 000 patients ). diabetic ketosacidosis may occur with increased levels of " ketone bodies " in your urine or blood . tell
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . - the other ingredients are : tablet core : microcrystalline cellulose ( e460 ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone ( e1201 ), silicon dioxide ( e171 ), magnesium stearate ( e470b ). film - coating : polyvinyl alcohol ( partially hydro
mifamurtide works by stopping the growth of certain bacteria which are resistant to the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults and adolescents aged 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy is not able to stop cancer cells from growing . it also helps to prevent cancer from coming back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines containing ciclosporin or other cineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can cause problems with your heart or blood vessels such as blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor if any
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of mepacts is 2 mg mifamurtide once a day . this will be taken once a week for 12 weeks . your doctor will decide how long you should take mepactor . your dose may be adjusted by your doctor up to 24 weeks depending on how you respond to your mep act treatments . your chemotherapy schedule will be adjusted according to your chemotherapy . the maximum duration of
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients taking mepacting ( transient ) paracetamol . if you experience fever during treatment with mepACT , you should contact your doctor immediately . stomach problems ( nausea , vomiting and loss of appetite ) have been experienced by some patients receiving chemotherapy . tell your doctor or nurse immediately if you have continuing fever and chills . these may be signs of an infection ( such as rash ). tell your physician or nurse if you notice any problems breathing , wheezing or any stomach problems .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expirability of the product does not require any special storage conditions . keep the vial in outer carton in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection has been stored at room temperature ( up to 30 ) for up to 6 hours . do this medicine if you notice any visible sign of deterioration . do throw away any medicines via wastewater or household waste .
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg of the active ingredient mifamate . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 " mepacts contains sodium ") 2 - dileoyls - sn - glyco - 5 - phosphate monosodium salt ( see also section 2 ) what mepACT looks like and
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness ( rosacea ) and redness of theface . rosica is caused by high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels causing the excess blood flow and reding of the area .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor or pharmacist before taking mirvasos : - if the medicine is injected under the skin . - if your doctor has told you that you are taking certain medicines for depression or parkinson ' s disease : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , moclobemide ), tricyclic antidepressants ( e. g . imipramine
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin on the face . this medicine is applied on the surface of your body . it should only be applied to areas where the body faces the most obvious problems . this applies to your eyes , mouth , nose or vagina . do not use mirvasos if you notice any change in the appearance of your skin . do use mirvao mirvasoa is applied only on the affected face . the treatment should be started with a small amount of gel ( a pea -
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain , discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects that may be signs of worsening of rosacea are : - decrease in the number of red blood cells , which may be symptoms of contact allergy ( see section 2 ' warnings and precautions '). - allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the tube and pumps tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasos contains methylparahsydroxy benzoate "), propyleneglycol . what mirvasoa looks like and contents of the pack mirvasop
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body from infection and cancer . bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in the lymph vessels of the body . the vegF protein is found on blood vessels where it stimulates the production of blood vessels that carry oxygen . bevoacizumsab causes tumour growth to
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . if you have any of these conditions , please tell your doctor before using this medicine . if any of them apply to you , tell your physician before using it . if your child is less than 6 months of age
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer . the usual dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight , given once every 15 days . your doctor may adjust the dose depending on your size and the amount of mvai you receive . if you are given more mvasis than you should if you have received more mvais than your doctor has recommended , you may be given 2 or 3 weeks of infusions . your dose may be adjusted or treatment stopped . if this medicine is
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects listed below are caused by mvasi alone . the most common side effects of mvasis are similar to those of chemotherapy . if you notice any of these side effects while you are being treated with mvasic , tell your doctor straight away . allergic reactions if you have an allergic reaction , including difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects include : severe side effects ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 and up to 48 hours at
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumumab in 1 . 4 ml of 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active ingredient bevackizumb in 1. 4 ml . each 16 ml vials contains 400 mg of of bevanacizumaab in 16 .5 ml of water . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the pack m
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . it works by inhibiting the growth of refractory mantle cell cancer ( mcl ) in your own white blood cells . it can be given by using autologous anti - cd19 - transfduced cd3 + cells . mantle cell lysisoma is a cancer that affects the immune system , especially the b - lymphocytes . mantlecell lymphoma b - cells multiply in an uncontrolled way and divide the lymph tissue in the bone marrow . tecart
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - are allergic or have had problems with the number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 ) - are white blood cell - are having autologous use ( see " warnings and risks ") tests and checks of your lungs , heart , kidney , blood pressure , infection or inflammation of your cancer ( graft -
tecartus is made from your own white blood cells . your cells will be collected by a specialised healthcare professional . your own cells will then be given to you by a catheter placed in your vein ( a procedure call leukapheresis ). your white blood cell will then come back into your blood . the first dose of your blood will be given by a doctor or nurse . it will be taken into a vein over 3 to 6 hours . the number of your whiteblood cells will slowly decrease over 2 to 3 hours . medicines given before tecartus treatment ( lymphodepleting chemotherapy ) the modified white blood
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention : very common side effects during the tecartus infusion ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , and fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness , decreased level of consciousness ), confusion , memory loss , and disturbances of brain function . difficulty speaking , sl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen equivalent to 150 ml . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours at 2 - 10 . do throw away any medicines via wastewater or household waste . ask your pharmacist
what tecartus contains the active substance is autologous anti - cd19 - transfduced cd3 + cells . each specific single infusion bag contains a dispersion of anti - cd19 car t cells ( equivalent to 68 x 2 cd3 cells ) and contains 106 anti - dcp3 + components . the other ingredients are sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartub is a clear , colourless to pale yellow solution for infusion . it is supplied in an infusion bag packed in a metal cassette .
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which are used to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi if you have : - ( see section 4 ) blistering of the skin - bullous pemphigoid . janura is not recommended if you suffer from a disease of the pancreatreas called pancreatitis . - if any of these apply to you , tell your doctor before taking this
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 mg taken by mouth once daily . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . you should continue taking this medicine as long as your prescribed dose . your doctor will tell you how many tablets to take . this medicine can be taken with or without food . if your doctor prescribes this medicine with certain other medicines , it may lower blood sugar . diet and exercise can help your body use its blood
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing , stop
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglioptin phosphate monohydrate equivalent to 25 mg sitaglptin . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack pink
xultophy is a low - sugar substitute for insulin which helps control blood glucose . it is used to treat type 2 diabetes mellitus in adults . diabetes is a problem where your body does not make enough insulin to control the level of sugar in the blood . the insulin that your body produces does not work as well as it should . it can also cause blood sugar to rise . insulin degludec ( a long - acting basal insulin ) is used when your blood sugar levels are too high . liraglutide ( a type of glp - 1 ) is also used as insulin during meals . xultophy
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if you have 39 diabetes . if you take a sulfonylurea such as glimepiride or glibenclamide . your sulfonyllurea dose should be increased every two weeks . your doctor will monitor your blood sugar levels regularly while you are taking xultop . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking xulinophy if :
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the usual starting dose of xultophy is 41 mg once a day . your doctor will tell you how many tablets of xulophy to take each day . you should take xultue for 8 weeks . you can take xupophy with or without food . xultide is supplied in a pre - filled dial - a - dose pen . the dose counter shows the dose to be taken
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( very common ( may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . serious hypoglycaemia ( may cause brain damage ) if you have low blood glucose , your bloodugar level may be too low ( hypoglycasemia ). see section " warnings and precautions " for more information . if you experience any of the following , stop taking xultophy and contact your doctor straight away : serious allergic reaction ( anaphylactic reaction
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening : store in the original package in order to protect from light . after opening : do not store above 30 . store at room temperature ( up to 25 ) for up to 8 weeks . after this time , use within 21 days . do away with the blister after 21 days , as this medicine does not require any special storage conditions
what xultophy contains - the active substances are insulin degludec and liraglutide . each vial contains 100 units of insulin degluudec 3 . 6 mg lirablutime in 3 ml solution . each ml contains 300 units of the active substance insulin deglioudec 10 . 8 mg liraagluteide . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ). - the solvent is water for injections ( see section 2 " xultphil contains sodium "). what x
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor 2 ]- erbb1 and her2 [ erbb2 - erbb3 ]- her2 - her3 - her4 - her2 . these proteins are involved in the growth of cancer cells . this medicine works by stopping the growth and spread of cancer proteins . this helps to stop cancer cells from growing . this is especially important for patients with cancer of the lung ( non - small cell lung cancer ). giotriff is used for your first treatment after
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you suffer from side effects associated with lung inflammation ( interstitial lung disease ) if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking giotralif if : you have liver problems your doctor may need to perform some liver tests before you start taking this medicine . you have a severe liver disease . you suffer or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif should be taken orally with food . swallow the tablet whole with a glass of water . you can take this dose with or without food . you may take this this medicine with or just after food . if you take more giotrinif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take this leaflet with you .
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotreif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea ( may cause up to 2 cases of severe diarrhoee ) fluid loss common ( might affect upto 1 in every 10 people ) low blood potassium ( may result in worsening kidney function ) diarrhoeas if you experience diarrhoeation after receiving giotrine , you should contact your doctor immediately . appropriate antidiarrhoeal treatment if you are receiving antidiar
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinb . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotralif looks like and contents of the pack giotrienif 20 mg film - coating tablets are white to off - white , round and biconvex .
what orkambi is orkmbi contains two active substances called lumacaftor and ivacaftOR . what orkami is used for orkamsi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found on the surface of cyst fibrosis transmembrane conductance regulator ( cftr ) in the lungs . the mutation causes an abnormal cftR protein . lumacafor works by helping the abnormal cctr protein
do not take orkambi if you are allergic to lumacaftor or ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that you have the f508del mutation , your doctor may need to change your dose of orkabi . talk to a doctor or nurse before taking this medicine if you suffer from liver or kidney disease . your doctor will monitor the dose of okambie . if any of these apply to you , tell your doctor . abnormal blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take adults and adolescents the recommended starting dose is 6 to 12 mg twice a day . your doctor will tell you how many orkambi tablet to take . the recommended dose is one 6 mg tablet twice a morning and one 11 mg tablet once a day ( morning and evening ). your doctor may prescribe orkandemi to be taken with 100 mg twice daily ( morning , afternoon and evening ) for 2 weeks . your dose may be increased every 2 weeks or decreased every 12 weeks . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . if you are treated with ivacaftor , you may experience some of the following : serious side effects that may occur with orkyambi : raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease , and the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg / 125 mg film - coated tablets each tablet contains 100 mg lumacftor and 125 mg ivacftir . each tablet of orkmbi 200 mg / 200 mg film film - coating contains 200 mg lumiacaftor or 125 mg of ivacaptor . each tablets of orkyambi 100mg / 125mg film - coat contains 200mg lumacaptir and 125mg ivacafor . the other ingredients are : tablet core : cellulose , microcrystall
what lynparza is lynparaz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ) that works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). cancer patients with parp inhibitors cause death by stopping cancer cells from producing an enzyme that helps repair dna . what lynparz is used for lynparparza has been prescribed for the treatment of ovarian cancer ( brca ) in patients with mutated ovarian cancer who have had previous
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given lynarza if any of these apply to you . if you think any of this applies to you , tell your doctor or pharmacist before you receive lynparz . if any part of the above applies to your child , tell the doctor or nurse . if your child is not sure , talk to the doctor , nurse or pharmaceutian before you have this medicine . low blood cell
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . the dose may be increased to 150 mg once daily . the doses of lynarza capsules are taken in combination with tablets . if you take more than a capsule of lynpalza daily , you may experience side effects of 8 mg / m2 . take the tablet by mouth once in the evening . if possible , take the tablets with a glass of water . if necessary , take your tablet at about the same time each day
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions may be listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 30 . store the capsules in the original package in order to protect from light . do throw away any lynparza capsules via wastewater or household waste . you can throw away these capsules yourself via wastewater . however , you can return them to the pharmacy or household rubbish . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack lynparparza is a white , opaque , hard capsule imprinted with " olaparaib 50 mg " and " astrazeneca logo on one side . lynparze is available in packs containing 112 hard capsules
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children of 14 years of age and older . the most common signs of overdose are breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an overdose . if you use more nyxid than you should if you think you have used more than the recommended dose , contact your doctor or pharmacist immediately . if possible , use this nasal spray 2 to 3 times a day .
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray . 1 . use the spray as instructed by your doctor . it is for use in the shoulders , ears , breastbone , sternum or inside the ear . use a fingernail to clear the mouth and nose of any blockages . 2 . do not use nyoid in the mouth or nose . 1 ). the most common signs of breathing is the chest moving ( up ) towards the chest . you may hear breathing sounds and breath on the cheek .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms ( see section 2 , " warnings and precautions "). opioid drugs may cause symptoms such as fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone ( as hydrochloride dihydrate ). the other ingredients are trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide and purified water . the total amount of nloxone in 0 . 1 ml is equivalent to a pre - filled nasal spray . what nyxoids looks like and contents of the pack nyxoidal is a single dose container containing one dose of nyxax . it is supplied in a carton containing 2 nasal spr
what ovaleap is ovaleape contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). follitroin ala is a hormone produced by the body called fsh . it is involved in the growth and development of the sacs ( follicles ) in the ovaries , and in the production of sperm . it helps to produce a immature egg cell . ovaleaps is used in women who are not ovulating and who are undergoing treatment with a medicine called " clomifene citrate " and who have not
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you know that you have large ovaries ( sacs of fluids that contain hormones that help the ovaries produce eggs ). if ovarian cysts are unexplained vaginal bleeding . if you think you have cancer in your ovaries , womb or breasts . if any condition that makes normal pregnancy impossible such as ovarian failure , early menopause , fibroid tum
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of this medicine is one injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor will tell you how many injections of this medication you need . the first 7 days of your menstrual cycle will be given to you . the medicine will be injected every day . the recommended starting dose of the medicine is 75 mg . your doctor may increase your dose to 150 mg once a day . your first dose of using this medicine will usually
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 this may affect up to 1 in 10 , 000 people . if you notice this type of reaction , your ovaleop injection may be stopped immediately . serious sideeffects in women lower stomach ache , nausea and vomiting . these may be the symptoms of ovarian hyper - stimulation syndrome ( ohss
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it has been stored for more than 3 days at room temperature . once removed from the refrigerator , the cartridge must be used within 28 days or discarded . do away with
what ovaleap contains the active substance is follitropin alfa . ovaleop 300 iu / 0 . 5 ml solution for injection : each cartridge contains 300 iiu ( 22 micrograms ) follitroin ala in 0 . 05 ml solution . ovalesap 450 iu in 0. 75 ml solution : each cartridges contains 450 iiu 33 microgram ( 23 microgram ) follitonropin alpha in 0 .. 75 ml . ovalap 900 iu per 1 . 5ml solution for injections : each carton contains 900 iiu , 66 microgram of follitopin al
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from 2 years of age to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ). candidaemia ( a form of fun fungal illness caused by candida sp ). in non - neutropenic patients ( patients with abnormally low white blood cells count ) to prevent candida esp . infections . the active ingredient in vor
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is taking any other medicines , including herbal medicines . the medicines listed below are taken before voricoazole accord treatment : 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if your baby has irregular heart beat ) rifampicin ( used used to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . your dose may be increased by 400 mg once daily for 12 hours or 24 hours or 200 mg once every 12 hours for 24 24 hours and 200 mg twice daily for 100 hours . depending on your response to treatment , your doctor may increase your dose to 300 mg once weekly . if you have mild
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate and of a short duration . serious side effects have been reported with voriconazole accord : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision ), blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura
what voriconazole accord contains the active substance is voricazole . each tablet contains 50 mg voricleazole ( as besilate ). voricoazole accord 50 mg film - coated tablets : each tablet has 200 mg vorbiconazose ( as mesilate ) the other ingredients are : tablet core : voricaazole acord 200 mg film- coating : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age and older who are at risk of getting ebola virus are recommended for a 2 - dose course of vaccinations . ebola is caused by the zaire ebolavirus and filovirus . this vaccine stops the spread of filov virus and gives the whole ebolairus away . it does not give you ebola fever disease . warnings and precautions talk to your doctor or nurse before you are given mvabeas . vaccinations are given as follows : - one dose of zabden
your child will receive the vaccination course . the vaccine should not be given if your child has had a severe allergic reaction to any ingredient contained in the vaccine ( listed in section 6 ). if your baby has had such a severe allergy reaction to an antibiotic called ' gentamicin ', the vaccine may not fully protect all children . if your newborn has had mvabea , if your infant has had any kind of a severeergic reaction to anything else , including any other vaccine injection . if you have fainted during or after the injection . warnings and precautions talk to your doctor , pharmacist or nurse before your child is given mv
the recommended dose of vaccine is a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the recommended dose is one dose of one vial of vaccine ( as zabdeno vaccine ) 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine will be given as a single dose . the first dose of the second dose is two doses . the second vaccination will be two doses of vaccine . primary vaccination first vaccination with zab deno red cap vial ( 0 . 5 ml ) second vaccination with mvabdenos yellow cap vials (
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth and swelling where the injection is given very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) feeling sick ( vomiting ) itching where thejection is given uncommon ( may affects up to1 in every 100 people ): redness and skin hardness where the needle is given generalised itching . the most common side effects ( may occur with up to one in every 1 , 000 people )
what mvabea contains the active substance is zaire ebolavirus 29 produced in tai forest ebolavirus nucleoprotein marburg in 0 . 7 ml of solution for injection ( containing 108 million international units ). the other ingredients are : chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass vial with a rubber stopper
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondronAT is used if you have a raised calcium level in your blood because of a tumour . this means that the calcium is lost from your bones . this helps to stop your bones getting weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - if there are low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronAT : - you have a rare side effect called osteonecrosis of the jaw ( onj ). onj can cause bone damage in the jaw . your doctor may decide to stop treatment with bondronatin if you have cancer or related conditions . onj may also occur after stopping treatment . on j is a painful condition that can be
this medicine is given to you by a doctor or nurse who is experienced in the treatment of cancer . it is given as an infusion into your vein . your doctor will carry out regular blood tests before you are given bondronat . your dose of this medicine will be adjusted depending on your illness . if you have breast cancer that has spread to your bones , it will usually be given 3 to 3 days after an infusion in your vein , usually lasting about 15 minutes . if there is a raised calcium level in your blood , it may be given as 1 to 2 days after the infusion . this may be repeated every 2 weeks depending on
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 in 10 , 000 patients ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). after dilution the infusion solution should be used within 24 hours . do this medicine if you notice particles in the solution or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack the concentrate for bondronate is a clear , colourless to pale yellow solution . it is supplied in a glass vial containing 1 ml or 2 ml of solution , with a bromobutyl rubber stopper .
what zeposia is zeposeia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zeposaia is used for zepoesia is a treatment for relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the entire body . how zeposesia works multiple sclerosis is a disease that attacks the immune system ( the body ' s defences ). white blood cell ( lymphocyte ) are important for the nerves of the brain and spinal cord and for the protection of the nerves . symptoms can include numbness , difficulty in walking ,
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if any of these apply to you , tell your doctor . if your doctor thinks that you have irregular or abnormal heartbeats ( arrhythmia ). if your heart is not working properly after treatment . if the patient has severe infection such as hepatitis
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need to take and how much you need . your doctor may also check your heart rate and may also prescribe you a ' treatment initiation pack ' for the first 4 weeks . the recommended dose is 4 capsules ( 0 . 23 mg ozanimod ) taken once a day . this will be taken once in the morning . then 1 capsule ( 0 .. 4 mg ) taken twice a day for the next 4 weeks ( total daily
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : common ( may affect up to 1 in 10 people ): slow heart rate urinary tract infection ( blood pressure uncommon ( may effect up to1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very common ( might affect more than 1 in10 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ). viruses and a type of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zeposa 0 . 46 mg : one capsule contains approximately 0 . 48 mg ozimod ( as hydrometrochloride ) and zepoia 0. 92 mg : two capsules contain approximately 0.92 mg ozmogromod (as hydrometeetrochrochrometrometrogetrometeeteete ): the other ingredients are : capsule shell : 0 . 03 mg : gelatin ,
what temybric ellipta is temybaellipta contains two active substances called fluticasone furoate and umeclidinium bromide ( vilanterol ). fluticasaone furaate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinia bromine and vilansterol belong to agroup of medicines known as bronchodilators . what temybarric elliptfa is used for temymbric elliptea is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long -
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric ellipte - if your child has asthma . temybre ellipta should not be used in children with asthma . - if the child has heart problems , high blood pressure , liver problems . - tell your doctor if your baby has tuberculosis ( tb ) of the lung . - your doctor should tell your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temybiric ellipte than you should if you have used more tembric ellipta than you need , contact your doctor immediately . symptoms of temybreric elliptfa may include a sudden attack of
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing do not improve after taking this medicine , contact your doctor immediately . pneumonia ( infection of the lung ) in copd is a common side effect that may occur with temybric ellipta . symptoms of a lung infection may include fever and chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat caused by a fungal infection ( candidiasis
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone fiformate , 65 microgram of umeleclidinnium bromeide and 55 microgram s of umaclidinia bromides and 22 microgramS of vilancerol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin . it works by attaching to the tissues around the skin and causing them to relax . this reduces the chance of getting an infection of the lungs called ' pneumonia '. zzinforoe is used in adults . zininforoe works by killing certain bacteria that cause serious infections .
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before taking zin foro . if any of these apply to you , tell your doctor before taking this medicine . if your doctor has told you that you have kidney problems . if this applies to you ( or you
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many tablets to take . the recommended dose is one 600 mg tablet once a week for 8 weeks . if you have some infections , your doctor may increase your dose to one 8 mg tablet twice a week . the dose is given by a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . your dose may be increased to 120 mg once daily . your physician will tell how many capsules to take and how often you should take an increased dose . the duration of treatment is 5 to 14 days . if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . treatment with zinforo may be interrupted or stopped , or medicines may be given to slow bowel movement ( see section 1 ). this may take up to 10 minutes . your doctor will do a blood test called a ' co
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinofo looks like and contents of the pack zinfforo is a pale yellowish to light yellow powder for solution for infusion in a vial . zinfo is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalinpfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with
do not take pregabalin pfizer - if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking preggabal pfiser . some patients taking preggabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregibalin psfizer . you should take pregagalin pfeizer once in the morning and once inthe evening . if you weigh 59 kg or more , you should continue taking pregafalin pfingizer once a
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregabil . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hydroxide ( e433 ). the
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this is a chemical in the body that is important for movement . parkinson ' s disease is a condition where people with parkinson's disease have sudden swings in their ability to move . people with this condition may also have difficulties moving . xadago can be used alone or in combination with levodopa or other medicines for parkinson' s disease .
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is taking any of any of : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , or tranylcypromine . - treatment for parkinson ' s disease or depression . - pethidine , a strong pain killer . - if the child is less than 7 months of age . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg twice a day ( 100 mg taken by mouth ). your doctor will tell you how many tablets of xadeago to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg once a day . take xadadago at the same time each day . swallow the tablets whole with a glass of water . xadag can be taken with or without food . if taking more xadagon than you should if you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : hypertensive crisis ( very high blood pressure that may lead to collapse ) - neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia , increase level of enzyme creatine kinase in your blood ) - serotonin syndrome ( causing confusion , hypertension , muscle stiffness , hallucinations and hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa . they are usually mild to moderate and usually disappear after a few
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadagon looks like and contents of the pack xadagus 50 mg film - coated tablets of 7 mm diameter with metallic gloss are white , round , biconc
zytiga contains a medicine called abiraterone acetate which is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the levels of testosterone in your blood when you have prostate cancer . ztiga is used in patients who have disease that has not responded to hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ) or who are taking another medicine containing prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the full dose of the medicine properly and which causes fluid retention in yourblood .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytig if you have severe liver damage or prostate cancer . this medicine should not be taken with this medicine . tell your doctor if any of these apply to you . if you think you may have been given too much of this medication . tell the doctor if you : have liver problems . have high blood pressure . have heart failure . have low blood potassium
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablet with a meal . do this by mouth and swallow the whole tablet with water . if necessary , take it with
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor may check your potassium regularly . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( see section 2 ' warnings and precautions '). low blood potassium ( seen in liver function test ). high blood pressure . urinary tract infection . diarrhoea . common ( might affect up to
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abiratingone acetates . - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round tablets with " 9 . 5 " debossed
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . addalimumab works by blocking the activity of a protein called tumour necrosis factor ( tnfÎ± ). tnfiya is used to treat the inflammatory diseases in these diseases :
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . if your / your child has moderate or severe heart failure . if you or your son has a serious heart condition . warnings and precautions allergic reaction allergic reactions may occur with symptoms such as chest tightness , wheez
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor may prescribe a different dose for you . your child ' s doctor will tell you how many tablets to take . the dose may be adjusted by your doctor if necessary . the doctor may also prescribe a higher dose for your child . the recommended dose is : for polyarticular juvenile idiopathic arthritis age and body weight how much to take adults the usual starting dose is 2 30 mg once a week . children and adolescents the usual maintenance
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 , " warnings and precautions "): - at the site of the last hefiya injection , allergic reaction ( including heart failure ), severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath , and swelling of the feet . tell a doctor straightaway if you have any of these signs and symptoms of infection , such
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre - syringe must be used within 14 days or discarded .
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalimab in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear
what ritemvia is ritemv contains the active substance rituximab , a " monoclonal antibody ". it sticks to a target in a type of white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dividing . what ritemvy is used for ritemvir is used to treat adults for the treatment of : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue that affects the immune system . it affects a type a of white cell called b - lipocytes . r
do not take ritemvia if you are allergic to rituximab , other proteins that contain ritukimab . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : - are less than 6 years old - have a severe active infection - have had a weak immune system - have severe heart failure or severe uncontrolled heart disease - have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris warnings and risks talk to the doctor or nurse before taking ritemvi if you have or have ever had a hepatitis infection . r
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need this treatment . your doctor may decide to stop giving you this medicine if you have any side effects . how ritemv is given ritemrovia is administered as a drip ( intravenous infusion ). medicines given before each ritemvo administration you will be given ritimvia together with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . if you are being treated for non - hodgkin ' s lymphoma , you will first be given one course
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of 10 ml contains 10 mg of the active ingredient of ritonuximb . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemv looks like and contents of the pack ritemvi is a clear , colourless solution for infusion in a glass vial . pack size of 2 vials .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine tacva is used in the treatment of colon , rectal , gastric , or breast cancers . capectabine cheva is indicated for the prevention of colon cancer after complete removal of the tumour by surgery . cape citabineteva may be used either alone
do not take capecitabine teva - if you are allergic to capecitabanine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has an allergy to any of these ingredients or any other ingredients , or to any other ingredient of this medicines ( listed under section 6 ) - if he / she has had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines containing fluorouracil ) - - if the child is pregnant - if they have low levels of white cells or platelets in the blood ( leucopenia , neutropenia or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface area taken once daily . this is equivalent to a daily dose of 150 mg . for adults , the usual starting dose is one 150 mg tablet once
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements per day . if you vomit more than once in a 24 - hour time period , you should stop taking the medicine and contact a doctor immediately . vomiting : if vomiting is more frequent than usual , you may vomit more easily than usual and you may lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and /
what capecitabine teva contains the active substance is capecitabiline . capecitavine tevas 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . furthermore , capecitafine teeva 500 mg film film - coat contains 500 mg capectabine . the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hypromeellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red (
silodosin recordati contains silodosino recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordat is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . it also helps to reduce your symptoms . silosin Recordati is used in adults to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if your child is going to undergo eye surgery - if there is cloudiness of the lens after cataract surgery - the coloured part of the eye is 26 darker than normal - if the colour of the iris is darker than usual - if any of these apply to your child ( see section 4 ). warnings , precautions and precautions before using medicine - if a loss
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule taken once daily , with or without food , at about the same time each day . you should take silodosein recordat for at least 8 hours every day . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . taking this purpose silodousin recordatin is for oral use . swallow the capsule whole with a glass of water . you can take silosinrecordati with
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . the most common side effect of silodosin recordati is dizziness . dizziness may also occur with occasionally fainting . if you feel weak or dizzy , contact your doctor . the symptoms of dizziness and faints usually disappear within a few minutes . if they do not disappear within several minutes , contact the doctor . if fainted occurs , contact a doctor immediately . if silodosiin
what silodosin recordati contains silodosein recordat 8 mg : the active substance is silodusin . each capsule contains 8 mg silodnosin . the other ingredients are mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). silodosesin recordatin 4 mg : silodmosin is the active ingredient . each capsules contains 4 mg siliodosin . these ingredients are : mannola , magnesium starchate , magnesium laurilulfate, gelatin , stainless dioxide ( i171 ), yellow iron oxide ( e172 ).
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzal mono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . ' essential ' means that the high bloodpressure does not have any immediate effect on the condition . high blood blood pressure , if not treated , can damage blood vessels in
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is less than 3 months pregnant . ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section .) - if the child has severe liver problems ( such as cholestasis or biliary obstruction ) which stop drainage of the bile from the liver and gall bladder . - if he / she has any other severe liver disease . - in patients with diabetes or impaired kidney function who are treated with a blood pressure lowering
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . the tablets should be swallowed with some water . you can take kinzalmono with or without food . try to take the tablet at the same time each day . if you take more kinzdalmono than you should if you have accidentally taken too many tablets , contact your doctor immediately . if possible , take the tablets with a glass of water . if necessary , take your tablet at least 20 minutes before or after food . kinzalino should
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( blood poisoning ) is a severe infection with whole - body inflammatory response that can cause rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) cardiovascular events uncommon side effects : uncommon side effect ( may impact up to one in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . once you have taken your medicine out , it should be used immediately . do this by gently squeezing your kinzalmono tablet from the blister until it is ready to be taken . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzaloo is available in blister packs of 14 , 28 , 56 , 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product produced by recombinant dna technology ( rdna ). the active substance is lonoctocog alfa . afstylfa is used to treat bleeding episodes in adults with haemophilia a ( inborn factor v iii deficiency ). factor vii is involved in blood clotting and helps blood to clot . patients with an increased tendency to bleed may also have higher levels of factor v ii . in patients with haophilia b , factor v viii helps blood clot .
do not use afstyla if you have had an allergic reaction to afstylea or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afstya . the dose and the batch number are recorded in your treatment diary . do not use more afstrya than your doctor has recommended . allergic ( hypersensitivity ) reactions are possible with afstsya . symptoms of allergic reactions may include hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphylaxis ), and a serious
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the dose of afstyla you receive will depend on the severity of treatment , the severity and location of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be mixed before use to avoid aseptic conditions . afstlva may be used with other medicines or solvents . see section 6 . the solution should
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding ) which may occur in patients taking factor viii medicines . inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). patients who have received previous treatment with factor v iii ( more or less than 150 days of treatment ), the risk of developing this condition is uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . do away with the vial . do this if you notice particles in it . do throw away any medicines via wastewater or household waste . ask your pharm
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 iu ( 2 . 5 mg / ml ). after reconstitution with 2 .5 mg / lonoectocog alpha , the solution contains 100 iu lonoCTocog aluminium . after reconitution with 1 . 5mg / ml , the resulting solution contains 200 iu of lonofactocog Î± . each 1000 iu vial provides 20 ml of solution . after administration with 2. 5 mg/ ml , injections the solution provides 400 iu / ml of lonicctocag
what praxbind is prax bind contains the active substance idarucizumab . idarucaizumb is a recombal agent of dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what praxBind is used for praxbinding is used to rapidlytrap dabigATran . how prax Bind works prax binds to pradxa in the form of a blood thin medicine that is absorbed by the body and helps to stop blood clot forming . how it works praaxbind helps to rapidly trap dabigatheran . what is the use
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfi ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking this medicine . serious adverse reactions have been reported with the use of prax bind in patients taking this type of medicine , dabigatran . other medicines to prevent blood clots dabigATran is a naturally occurring substance in the body which helps to prevent formation of blood clumps . medicines
the recommended dose is 5 mg / kg body weight ( equivalent to 2 . 5 mg dabigatran ). this medicine will be given to you once a day . you will be monitored for the development of a new type of blood clot formation . you may be given one 5 mg tablet of this medicine once a week , as long as it is infused into a vein . your doctor will decide how much of this medication you need . your treatment will be supervised by a doctor experienced in the prevention of blood clot formation . dabigATran may be administered to you for up to 24 hours after you have been given this medicine .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack the solution for injection is clear to slightly opalescent , colourless to slightly yellow solution . it is supplied in a clear glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and monotherapy phase oftreatment . - in children 3 years of age and older and adult patients with malignant glioma , such as glioclastoma multipurpose or anaplastic astrocytoma . temmedac is also used in children who have
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . if your number of blood cells is severely reduced ( myelosuppression ), your white blood cell count and platelet count may decrease . these blood cells are important for fighting infection and for proper blood clotting . your doctor will
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take with temomedic to prevent nausea and vomiting . if you currently have newly - diagnosed glioblastoma multiforme , treatment is divided into two phases : treatment together with radiotherapy ( concomitant
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , stop temomedac treatment and contact your doctor immediately . there may be a reduction in certain kinds of blood cells . this can cause increased bruising or bleeding , anaemia ( a shortage of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can be severe . if this happens ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do use temomedac if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedat 5 mg : each capsule contains 5 mg temozolsomide ( as mesolomides ). temomedacon 20 mg : one capsule contains 20 mg tem ozolomine ( as temolomamide ). temmedac 100 mg : two capsules contain 100 mg temzolomile ( as besolomid ). temarthac 140 mg : three capsules contain 140 mg temosolomage ( as Mesolomix ). temarmac 180 mg : four capsules contain 180 mg temuzolomime ( as
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis for sexual performance . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by blocking the blood vessels in your penis . this allows your penis to work normally and allows you to achieve erectile function . calineis is used to prevent erectile disease in adult men . cocalis is also a medicine used
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are intolerant of organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali . if you have been previously treated with any of these medicines , do not take any more of the above . if your dose of nitrate is too low , tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual dose is between 5 mg and 2 . 5 mg . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show them the pack . if necessary , show the doctor the pack of tablets . if not , show it to your partner
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( may occur with nitrates ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . stop taking cialis and seek medical help immediately if you experience such an erection . see section 4 , " warnings and precautions ". sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects very common ( may affect more than 1 in 10 people ) uncommon ( may affects up to 1 in 100
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), iron ox red ( e129 ),
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglide is used to treat type 2abetes in adults . treatment is usually started with diet and exercise and weight reduction . your blood pressure may be raised when eny glid is taken in combination with metformin . if you have diabetes , enylid
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if your dose is too high . if any combination of eny glid or gemfibrrozile ( a medication used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the maximum recommended dose for adults is 30 mg once daily . the dose may be increased by 4 mg once every 30 minutes , or by 16 mg once each day . your doctor will tell you how many tablets you need to take to control your blood sugar . if you take more enylid than you should if you accidentally take too
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . however , hypoglycanemic unconsciousness may lead to coma . allergy allergy ( may occur in up to1 in 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects may include : common ( may effect up to one in 10 users ): stomach
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ), red iron oxide (< e172 ) only in the 2 mg tablets . what eny glid looks like and contents of the pack enylid 0 . 05 mg tablets
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine myla is used for azac citidine mylon is used to treat adults . what it is usedfor azacuitidine myel is used in adults . azacitant mylan can be used : after a stem cell transplantation in adults with higher - risk myelodysplastic syndromes ( mds ), chronic myelomonocytic leukaemia ( cmml ), acute myeloid leukaemic ( aml ). these are diseases that affect the bone marrow
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine mylan : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition ( such as heart attack or lung disease ). blood test before and during
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azaccitidine myl is needed . your dose of this medicine will be calculated by your doctor based on your height and weight . azacacitine mylan is given every 3 weeks as part of this " treatment cycle " which consists of 4 treatment cycles . each cycle lasts 6 weeks . this medicine is given under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms or signs of kidney failure . a fever , which might be a sign of an infection due to low levels of white blood cells .
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special temperature storage conditions . once the suspension has been diluted it should be used immediately . the suspension should be administered within 1 hour . the azacidine myla suspension is for oral use only and must be diluted before use . if you are not able to take water for injections , the suspension can be stored for up to 8 hours in a refrigerator ( 2 8 ). the
what azacitidine mylan contains - the active substance is azaccitidine . one vial of powder contains 100 mg azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaciticidine . - the other ingredient is mannitol . what azacituidine myl looks like and contents of the pack azacitonidine mylon is a white powder for suspension for injection in a glass vial containing 100 mg of azacito . it is supplied in packs containing 1 or 7 vials . not all pack sizes
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue in the eye . timoll is a beta blocker that reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - if the child has wheeziness , difficulty in breathing , long - standing cough or breathing problems . - tell your doctor if the patient has severe hay fever or a slow heartbeat . - warnings and precautions talk to your doctor before taking duotra : - if a child has heart failure ( a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye or eyes twice a day . do not use duotrav in both eyes . use durotrav only once a day , at the same time each day . use it in both your eyes and your eyes . do this every day , as long as your prescribed dose is the same as for your other eyes . try to use dudoserav at the right time each morning and evening . do the following : - use eye drops twice a morning ( 1 drop in
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be kept in the bottle to help protect your eyes . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects affecting the eye eye redness . common side side effects these may affect up to 1 in every 10 people effects affecting how the eye surface inflammation or surface damage can cause eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning or stinging . uncommon side effects this may affect upto 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg travostrost and 5 mg timolole ( as timolool maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg - the ingredients are : boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . acidity levels may be increased when reconstituted with water for injections .
nplate ' s active ingredient is romiplostim . it is a protein used to reduce low platelet counts in patients with a weakened immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important in keeping platelets in your blood healthy , as they help to prevent blood clots from forming . very low platelets counts can lead to bruising and serious bleeding ( see section 1 ) in patients who have had their spleen removed . in patients suffering from chronic itp who have not previously received cort
do not take nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). - if allergic to other medicines containing escherichia coli ( e . coli ). warnings and precautions before taking nplate , tell your doctor if you have a low blood platelet count ( thrombocytopenia ). nplate may reduce your platelet counts , which may increase the risk of blood clots . blood clhes are important for blood clotting . - if your doctor has told you that you have liver problems . - you are over 65 years old .
nplate is given to adults and adolescents ( aged 1 to 17 years ) who are able to take nplate . how nplate is administered nplate will be given as an injection under the skin ( subcutaneous ) at a dose of 1 mg / kg . how often nplate should you be given nplate ? your doctor will check your platelet counts regularly . you will have regular blood samples taken to count your platelets . your platelete count will be checked regularly . your doctor may also increase the dose of nplate if you have any physical symptoms that show that your blood platelet count is at very high levels (
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing ( blood clot ), a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , ind
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romiplopim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each pack contains 125 ml romiploseim . the other ingredients are : nplate 250 mg powder : n plate 250 mg : npl 375 mg : romiplustim in the solution for infusion . each box contains 250 mg romoplostim and 250 mg of romipliplostime in a deliveryable amountof 0 . 5 ml solution , each pack contain
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help to relieve breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on copd .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - tell your doctor if you have kidney problems - tell the doctor if any of these apply to you . - tell you doctor if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). your doctor may decide to stop treatment with tovannor breezer . if you use
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhaler twice a day . you should inhale this medicine at the same time each day . the recommended starting dose is one capsule twice a week . this medicine should be used every 24 hours . your doctor will tell you how many capsules to use . the maximum recommended dose is 75 capsules twice a night . you can use this dose at any time of the day . how to use this medicinal product this medicine comes
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopromroniumbromide and 50 microgramS glycopyronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopYRronium per inhalation dose . - the other ingredients of the inhation powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44 microlitre
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which have similar calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms ( e . g . schizophrenia ) hearing , seeing things which are not there , mistaken beliefs , incoherent speech and behaviour , emotional flatness , feeling depressed , guilty , anxious or tense . adasve can also help to reduce the effects of bipolar
do not take adasuve if you are allergic to loxapine or any of the other ingredients of amoxaprine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing or shortness of breath , as these may be signs of lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or short shortnessof breath . these may occur 25 in adults . neuroleptic malignant syndrome ( nms )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day , taken once in the morning and once in 2 and 4 . 5 hours , taken twice a night . you should take adasuve every day until your condition improves . you can take adasve with or without food . it is best to take adamsve with a meal or between meals . it does not matter whether you take adarasuve with food or with a drink . it should be taken with or just after a meal . you
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have any of the following side effects : any breathing symptoms , wheezing , cough , shortness of breath , chest tightness which may become irritating and difficult to control . these may be signs of problems with your airways ( asthma or copd ). light - headedness or fainting . these could be signs that your blood pressure is not being controlled properly . worsening agitation , confusion , fever and muscle stiffness . these can be signs for a severe condition called neuroleptic malignant syndrome . other side effects
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with adasuves if you notice any visible sign of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . one delivers 4 . 5 mg loxpine . what adasuves looks like and contents of the pack adasuva 4 .5 mg inhalers are white to off - white plastic inhaler , imprinted with " loxphine " on one side and " adasuv 4 . 0 " on the other side . each inhaler is packed in a sealed foil pouch . adasuvey 4 . 95 mg inhaler comes in packs containing 1 or 5 inhalers
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called anti - metabolites . what azaccitidine betafarm is used for azaciticidine betaparm is for use in adults . azacuitidine betagarm is given as a stem cell transplantation in adults for the treatment of : higher - risk myelodysplastic syndromes ( mds ) chronic myelomonocytic leukaemia ( cmml ) acute myeloid leukaemic ( aml ). these are diseases that
do not take azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine betapham : - if : you have decreased counts of platelets , red or white blood cells - if any of these apply to you ( or you are not sure ), talk to a doctor or go to a hospital straight away . - if the patient has kidney disease . - have liver disease .
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you the dose of this medicine to take . your dose will depend on your height and weight . azaccitidine betafarm is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) by your doctor or nurse . it may be given under different skin areas ( such as the thigh , tummy or upper arm ). if you have any further questions on
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( e . g . abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms due to kidney failure . a fever , which might be a sign of an infection due to low levels of white
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . any unused azaccitidine betabarm must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be used within 45 minutes . the azacituidine betafarm suspension is for oral use . it is for use with water for injections . the syringe contains 8 ml of solution . the zacitine betapham suspension is also for use for injections and is for immediate use . the package contains 8 vials
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azaccitidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaciticidine . - the other ingredient is mannitol ( e421 ). what azacituidine betafarm looks like and contents of the pack azacacitid betapham is a white to off - white powder supplied in a glass vial containing 100 mg of azacitoidine .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which the body produces too much glucosylceramide . this is especially toxic for the body ' s spleen , liver and bones . when eliglustate is taken with glucosyleceramide , it can cause your affected organs to relax . this medicine is used to treat this condition . your doctor will test your body to make sure that you do not have too much of this medicine . your dose of cerdelga will be adjusted by
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is not able to tolerate medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - if it is not possible to tolerate moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). these medicines are usually given to you by your doctor to reduce your body ' s ability to tolerate them . warnings and precautions talk to your doctor before taking cerdelg .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet twice a day with food . the amount of metaboliser that you need to take varies depending on your condition and body surface area . the dose of metabolizer that you take is one 84 mg tablet twice daily . swallow the tablet whole with a glass of water . if you take more cerdelga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take the tablet with a meal . do not open the sleeve . you can take the
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustit . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgi
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). it reduces the amount of calcium in the blood in adult men when it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not use zoledron acid hospir if you are allergic ( hypersensitive ) to zoledic acid , another bisphosphonate ( the group of substances to which zoledrine acid belongs ), or any of the other ingredients of zoledicle acid hospiral ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using zoledric acid hospiar : if you have or have ever had a kidney problem . if you experience pain , swelling
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ). ' iv ' administration is recommended in order to reduce dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg . if you have a kidney problem , your doctor may decide to lower the dose depending on your kidney problem . how often zoledic acid hospir is given your doctor will decide if you should be given a higher dose . if your doctor determines that the dose is too low , you may be given an additional dose of zoledron acid hospire
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain blood tests ) low level of calcium in the blood uncommon ( may affects up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness in the jaw , and loosening of a tooth . these could be signs of bone damage in the g
keep this medicine out of the sight and reach of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zoledronic acid hospira contains the active substance is zoledron acid . one vial of zoledor acid contains 4 mg zoledrine acid . the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledico acid hospir looks like and contents of the pack zoledic acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains rolapitant which is used to treat adults with cancer feeling sick ( nausea ) or being sick ( vomiting ) at the start of cancer treatment chemotherapy . how varuby works rolapit works by stopping the growth of nerve cells in the brain that help you to fight off the effects of vomiting . people who are sick ( sick ) may also be given rolappit to stimulate these nerve cells to produce more energy and help to fight nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking varubry if you : have depression or difficulty sleeping ( see section 2 " warnings and risks "). this medicine should not be used 27 if you have severe liver or kidney problems . if you currently take certain medicines containing rifampicin ( used to treat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . you may take varubsy with food or between meals for up or about 2 weeks before your chemotherapy cycle . your doctor may change your dose , depending on how you respond to chemotherapy . if you take more varubys than you should if you have taken more varubsys than your doctor tells you to , contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swelling or skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , as this may indicate that you may need appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache ; constipation ; feeling tired uncommon ( may effect
what varuby contains the active substance is rolapitant . each tablet contains 90 mg rolapit . the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubry is
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and microcopyrroneium belong to a group of medicines called bronchodilators . they relax the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to agroup of medicines known as corticosteroids or steroids . corticoposteroids reduce the swelling and irritation ( inflammation ) in the small airways in the
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you have : heart problems - if your doctor has told you that you have an irregular or fast heartbeat - if the patient has thyroid gland problems - diabetes - if he / she has high blood sugar - if there are seizures - if any of these apply
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the medicine should be inhaled by mouth or inhaled through a tube or a tube . you should inhale the content of one capsule at a time . it is important that you continue to use enerzair breezhaler until your asthma is controlled . if your symptoms do not improve after using enerz air breez inhaler , contact your doctor . how to use the active substance in this pack , you will find an inhaler and capsules that contain the medicine . the inhaler is for inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop taking enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side effect may include : very rare ( may affects more than one in 10 , 000 people ): sore throat , runny nose , sudden difficulty breathing , feeling of tightness , wheez
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate ( asacetate ), 63 microgram of glycopyronium bromides , 50 microgram glycopierronium , 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram indacatedol (as acetate ) 58 microgram ( glycop
clopidogrel acino pharma gmbh contains the active ingredient clopidigrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmÃ¡ gmbhs is taken to prevent blood clubs ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopiprel or any of the other ingredients of clopidineogrel agabilil ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelacino pharmara gmbhl . if your doctor thinks that you may be at greater risk of bleeding than you are if you : have
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopidineogrel aclara gmb h per day to be taken orally with or without food . you can take cloclopidoggingrel acine pharma h for as long as your doctors prescribe it . if you take more clopidoogrel agclara pharma go to the nearest hospital emergency department immediately . if possible , show the doctor your pack of tablets . if
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 5 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 1, 000 ). not known ( frequency cannot be estimated from the available data ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplogrelacino pharmara gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrel akino pharmÃ¡ gmb h looks like and contents of the pack clopidineogrelac
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are taking medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine ( which is a nucleosides analogue reverse transcriptases inhibitor ( rrti ) and tenofovir disoproxil ( a nucleoide analogue reverse transcriptase inhibitor , nrti ). delstrigo can be used to control hiv infection in adult patients ( aged 18 years and older
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if your doctor has told you that you are taking any of : - the following medicines : carbamazepine , oxcarbazepine ( medicines to treat tuberculosis ) - st . john ' s wort ( hypericum perforatum , a herbal remedy used to treat depression and anxiety ) - products containing mitotane (
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for treating hiv infection . the usual dose is 1 tablet a night . your doctor may prescribe you certain medicines ( such as doravirine ) to help you stay on the diet and reduce the amount of medicines you take . taking this medicine swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . taking delstriga with food and drink you should take del
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea , stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms ( such as pain or stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion and suicidal thoughts
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are 100 mg doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ). the other ingredients are croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumate . a coating material containing carnauba wax e903 contains hypromllose , iron oxide yellow ( e172 ), lactose monohydrate , titanium dioxide e171
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression , such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in combination with another antidepressant , which is also used in children and adolescents ( see section 2 , " antidepressant medicines and spravatos ").
do not use spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out ) or bleeding in the brain . - if recently had a heart attack . within 6 weeks of starting treatment , a temporary increase in blood pressure can lead to serious complications in these conditions . tell your doctor before using spravate if any of these apply to you . if you think any of this applies to you , tell your
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravat nasal spray is for oral use . the nasal spray device is for use in adults . use in children and adolescents the recommended dose is 1 spray ( 2 sprays ) per kg body weight . use 3 nasal spray devices per kg of body weight per day . use one nasal spraydevice per kg weight per kg per kg , for 4 weeks . use spravata every day for 2 weeks . this medicine is used to prevent nausea and vomiting in children aged
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ): feeling disconnected from others , feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch , especially in the mouth area spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ) feeling extremely happy , euphoria , feeling agitated , feeling anxious , eyes , ears or sense of touch are altered or mimicked irritable panic attacks change in perception 37
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine delivers a clear , colourless solution to your body . it is supplied as a single - use nasal spraydevice . spravata is available in packs containing 1 , 2 , 3 or 6 nasal spray devices . eachnas
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer is caused by a change ( mutation ) in a gene responsible for producing melanoma cells . zelborald targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . do not use more zelberaf than your doctor has recommended . allergic reactions if you have allergic reactions to zeloraf , tell your doctor or nurse immediately . zelbaf can cause any symptoms of an allergic reaction , including swelling ofthe face , lip or tongue ), difficulty breathing or rash and / or fainted sensation .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day for 8 weeks . your doctor may increase your dose to 4 mg once a week if you experience side effects . your treatment with zelboraf may be stopped if you suffer from vomiting . take zelbaf with food . zelberaf should be taken on an empty stomach . swallow the tablet whole with a glass of water . do not crush or chew the tablet . if you take more zelbearingaf than you should if you accidentally
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur : swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you notice any of the following symptoms : radiation treatment may cause side effect associated with radiation . zelbaraf treatment may also cause radiation to affect the skin , esophagus , bladder , liver , rectum , and lungs . tell your physician immediately if any of these symptoms occur : skin rash , blistering , peeling or discoloration of the skin shortness
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the expirability refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any particles in the solution or if the blister is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of ve murafenb ). the other ingredients are hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelbaf
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ). asa belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels become thinner . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clubs forming in hardened arteries , a process known as atherotrombotic events , which can lead to stroke
do not take duoplavin - if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) - if your child is allergic to other products called non - steroidal anti - inflammatory products - if the child has painful and / or inflammatory conditions of muscles or joints - if he / she has a medical condition ( e . g . asthma , nasal discharge , runny nose , polyps or any type of growth in the nose ) - whether the child is currently suffering from a medicalcondition that is currently causing
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many tablets of duoplavin to take and how long you should continue to take your medicine . the recommended dose is one tablet a day . if you take more duoplin than you should if you have had a heart attack , you should contact your doctor immediately . if possible , contact your nearest hospital emergency department because of the increased risk of bleeding . if necessary , take your tablet with you . if more duplavin than is recommended , contact a doctor or
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 of the active substances , clopidogrel , acetylsalicylic acid (asa ), and acetylsuxypropylcellulose . the other ingredients are : 75 mg : clopridogrel ( hydrogen sulphate ), 75 mg acetylSalicylic acids , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylecelluloses , maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonididine tartrates belongs to an active group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinz is used to lower pressure in the eyes in adults aged 18 years and older who have been previously treated for eye conditions such as glaucoma , ocular hypertension ( high pressure in one or both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you use certain antidepressants if you stop taking any antidepressant medicines if you suffer from severe kidney problems if you develop too much acidity in your blood ( hyper
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid contact with the drops in your eyes . wash your hands thoroughly after using simbrine ( see section 1 , " how to use simbrinusza "). remove the cap and snap collar . before using the medicine , twist off the cap . hold the bottle with your fingers . tilt the bottle back . pull down the eyelid with a clean finger and insert a ' pocket ' between the eyelids and the eye . the drop will go
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction such as severe skin reactions , rash , redness or itching all over your body or eyes trouble breathing , chest pain , or irregular heart beat tell your doctor immediately extreme tiredness or dizziness . the frequency of side effects listed below has not been established . if you are taking simbrinza with other medicines containing brinzolamide or brimonidine , tell your physician immediately . common side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . after first opening , use within 4 weeks to prevent infections . do away with the bottle after this time period . use a new bottle if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of a brimonine tartrate equivalent to 1 . 3 mg of of brimonate ). - the other ingredients are benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonsium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified
what filgrastim ratiopharm is filgrasteim ratisopharm contains the active substance filgrastaim . filgrasterim is a protein produced by biotechnology in bacteria called escherichia coli . it is very similar to a natural protein ( granulocyte - colony stimulating factor ) produced by your own body . filfilgrastima stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgnastim allows your body to produce more white blood cells quickly . what filgratim
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgrateim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrustim ratitopharm : - if a cough , fever or difficulty breathing has been reported . - if your child has a pulmonary disorder . tell your doctor if your baby has any of these side effects . - sickle cell disease 57 - if the child gets left upper abdominal pain or pain at the tip of your shoulder . - tell your child if
how much filgrastim ratiopharm is given the amount of filgrasteim ratisopharm you will receive will depend on your condition and on how well you respond to filgrasterim ratitim . your doctor will tell you exactly how many tablets of filgnastim ratiopharm to give to you . filgrateim ratiotopharm treatment will be started by a doctor who is experienced in the use of chemotherapy . the usual dose is 0 . 5 mg per kilogram bodyweight given once every 60 days . your treatment will usually last for 14 days . some disease types may be
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . if any of the above apply to you , tell your doctor before you are given filgrimastim ratiopharm . your doctor will check whether you are still being treated . regular blood tests before and during treatment with filgrasteim ratisopharm , your doctor may check the number of neutrophils ( a type of white blood cells ) in your blood . this
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do do not take filgrasteim ratisopharm if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasim . each ml of solution for infusion contains 60 mg of filgrasteim . filgrasterim ratisopharm 30 mg / 0 . 5 ml : each vial contains 30 mg of filmgrastime in 0 . 05 ml solution . filgnastim ratiopharm 48 mg / 1 ml : one vial containing 48 mg of the active ingredient filgracyim in 0. 8 ml solution for injection . - the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol ,
what riluzole zentiva is riluxole zenziva contains a substance called rilusole which belongs to the nervous system . what rilizole zsentiva is used for rilukole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ) motor neurone disease ( ms ). ms affects the nerve cells that make muscles , causing weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurONE disease may also cause too much glutamate ( a chemical messenger ) in the brain and spinal cord . rilzole zintiva works
do not take riluzole zentiva - if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). - if any liver disease has been reported . - if your doctor has found that you have increased blood levels of some enzymes of the liver called transaminases . - tell your doctor if you think you may be pregnant . warnings and precautions talk to your doctor before taking rilzole zenta - if : you have any liver problems - yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth once a week for 12 weeks . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , contact your physician immediately . do not take a double dose to make up for a forgotten dose . if your child swallips some tablets whole , contact
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). riluzole zentiva may cause a decrease in the number of white blood cells . your doctor will take a blood sample to check for this . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests while you are taking
what riluzole zentiva contains the active substance is rilusole . the other ingredients are anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round and marked with ' 50 ' on one side and ' ril ' on the other side . riluxole zENTiva is available
emgality contains the active substance galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ), which is involved in migraine . increased levels of cgrm in the blood can lead to an increased risk of migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older who have experienced at least one or more migraines before . emigality has been shown to reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease . serious cardiovascular diseases can lead to allergic reactions emgally may cause serious allergic reactions . these reactions may be 40 minutes or more long . if you experience a serious allergic reaction , you should contact your doctor immediately . such signs and possible side effects are listed in the section 4 . children and adolescents emgali is not recommended for children and teenagers under the age of 18 years . other medicines and emgals tell your doctor or pharm
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg of emgally given as an injection under your skin ( subcutaneous injection ). you may receive your emgalis injection at home or at the hospital , but only after proper training . if you receive more emgals than you should if you have received more than 240 mg , tell your doctor . do not take a double dose to make up for a forgotten dose . if possible , show your doctor the pack of emegality . if any further questions on the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash , raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . after first opening , the blister may be kept at room temperature ( up to 8 ) for up to 7 days . do away with the blister if it is not used within 30 days . store this medicine in the outer carton in order protect from moisture . do throw away
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is clear to slightly yellow . the syringe is provided in a pack containing one single - dose pen . pack sizes of 1 , 2 , 3
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( when the blood vessels in the liver become damaged ) in which blood clots form and which cannot be removed with medicines obtained prior to a stem cell transplantation . defibrobrotide works by helping the blood vessel to open and close , so that the blood clasts can form . your doctor has prescribed this medicine for you .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have bleeding , especially heavy bleeding if you need a blood transfusion or surgery if you suffer from problems with blood circulation or a constant blood pressure ( see section 1 ) have recently taken other medicines ( medicines to reduce blood clotting ) such as acetylsalicylic acid , heparins
the treatment with defitelio will be started by a doctor who is experienced in the treatment of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . your doctor will monitor your symptoms regularly . if you have any further questions on the use of this medicine , ask your doctor or nurse . if more than 18 days have passed since you received defiteloio , your doctor may decide to give you a lower dose . if a dose is missed , tell your doctor , nurse or pharmacist .
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor straight away if you notice any of the following side effects . if you get any of these side effects seek medical advice immediately : common ( may affect up to 1 in 10 people ): low blood pressure common ( might affect upto 1 in every 10 people ) bleeding in general bleeding in the nose bleeding in parts of the brain bleeding in part of the gut vomiting blood bleeding in other parts of your body including the lungs bleeding in blood in the urine and in the mouth bleeding in areas of the
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use defnitelio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibroide . after dilution , each ml solution provides 80 mg of the active ingredient of defabrotide ( as sodium citrate dihydrate ). the other ingredients are hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow solution for infusion . it is
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it reduces the amount of the virus in your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklanza are : - tablets containing a medicine to treat your hepatitis c infections . - tablets with a medicine containing a protein called amlodipine . - tablet containing a drug called amlanodip
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with any of your following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital used to treat epileptic seizures rifampicin , rifabutin and rifapentine antibiotics used to prevent tuberculosis dexamethasone , a steroid used to protect against allergic and inflammatory diseases , medicines containing st . john ' s wort ( hypericum per
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is one 60 mg tablet once a day . do not chew or break the tablet . do this to avoid unpleasant taste . dakinza may be taken with some other medicines . if you take more daklza than you should if you have taken more dailinza than your doctor tells you to , contact your doctor . if possible , take your tablet with a glass of water . do so at the same time each day . if necessary , take it
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir or ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when dacklinza in combination of sofosebuvir and ribavir the following other side effects are reported : common ( likely to affect up in every
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) 51 what daklineza looks like and contents of the pack 30 mg film
proquad is a vaccine to prevent measles , mumps , rubella , chickenpox ( varicella ) viruses . when a person is given the vaccine , the body ' s natural defences ( antibodies ) will make the measles , including mumps and rubella . when the immune system ( the body ) attacks the varicellis , the antibodies may help to prevent diseases caused by these viruses . proquad is used to prevent adults from getting measles , which may be caused by mumps or rubella or chickenpox . the vaccine is given to infants and children 12 months of age and older . pro quad is used in children
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder or type of cancer that affects the immune system ( treatment with medications that weaken the immunesystem ) if your doctor has recommended low - dose corticosteroid therapy ( for asthma or replacement therapy ) if any of these apply to you , tell your doctor . if you suffer from a weakened immune system , such as a disease ( including aids ), congenital or hereditary immunodeficiency ( immune competence
proquad is given by injection into the muscle or under the skin ( usually in the thigh or upper arm ). injections will be given into the upper muscle ( usually the thigh area ) or upper upper arm . if you have low levels of platelets , the vaccine should not be given . injecting under the sunbed or under your skin may increase the risk of bleeding . proquad is injected into a blood vessel . pro quad is given as an injection into a healthy blood vessel ( subcutaneously ). proquad can be given to infants and children from 9 months of age and adolescents from 12 months of ages . it is not recommended to
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ) other side effect that have occurred with pro quad include : very common ( may affects more than 1 in
what proquad contains the active substances are : measles virus1 , edmonston strain ( equivalent to 3 . 00 mg mumps virus1 and jeryllynnâ¢ level b ) strain ( corresponding to 4 . 30 mg mrc ) rubella virus2 , strain (ivalent to 3. 00 mg varicella virus3 and merck strain ( approximate mrc ). the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 and hanks ' salts
jylamvo is a substance produced in the body known as an anticancer medicine which reduces unwanted reactions . it is an immunosuppressive agent . by reducing the activity of the immune system , jylamv is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( for example , polyarthritic forms of joints ) severe juvenile idiopathic arthritis ( jia ) in children 3 years of age and older . it may be given alone or in combination with non - steroidal anti - inflammatory drugs ( nsaids ) to treat inadequate o severe or disabling psoriasis in adults
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if any of these apply to you , tell your doctor before using jylimvo . if you develop blood disorders ( e . g . bone marrow hypoplasia , leukopenia , thrombocytopenia , significant anaemia ) 34 if you know that you have or have ever had a weakened immune system , if you think you have ever been in close contact with someone who has
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jylamvo is one tablet once a day . if you use more jylimvo than you should if you have used more jyslamvo than your doctor tells you to , you may experience severe side effects , possibly even death . your doctor will monitor you closely during the treatment . rheumatoid arthritis , severe juvenile idiopathic arthritis , and severe psoriasis if you suffer from severe psoriatic arthritis , jylemvo may be used as a
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching on the whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising , nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the medicine should be used immediately after dilution to prevent accidental spillage . the product should be disposed of within 3 hours . any unused medicine or waste material should be returned to the pharmacist . this includes any unused product or waste materials not listed in this leaflet . do ask your pharmacist how to dispose
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotexate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydrobenzozoate "). what jyarmvo looks like and contents of
what enurev breezhaler is this medicine contains glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to help breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to open the airway and makes it easier to get out and out
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma ( difficulty passing urine ). warnings and precautions talk to your doctor or pharmacist before using treatment with enurevi breez inhaler . if you have any of these conditions , stop using this medicine and tell your doctor immediately : - tightness of the chest , coughing , wheez
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhaler once a day . you should use this this medicine for 24 hours at a temperature of 75 to 75 Âºc . you can use this medication at any time of the day , with or without food . this medicine is for inhalation use . this means that you use it every day . this includes any time between the use of an inhaler and capsules ( in blisters ). the medicine is inhaled through inhalation powder . the capsules should be swallowed whole with water
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ): irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness . allergic reaction including swelling mainly of the tongue , lips , face or throat ( angioedema ). if any of the side effects gets serious , tell your doctor . some possible side effects ( frequency cannot be estimated from the available data ): frequency not known
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms of glycoprroniumbromide , equivalent to 50 microgram of glyopyrronia . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram glycopriteium . - the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what enurevan breez inhaler looks like and contents of the pack enurevo breezker 44 microlitre inhalation
riximyo contains the active substance rituximab , a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this target , it stops the cell from growing and dividing . how riximyo works riximusyo is used for the treatment of several different conditions . rixima is used to treat : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue that affects the immune system . it affects a
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using rixigyo . if any
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may decide to change your dose . riximusyo is given as a drip ( intra - venous infusion ). medicines given before each rixima administration you will be given rixiu ( either alone or in combination with other medicines ( premedication ) to reduce the risk of side effects . your doctor will also tell you how long you should continue your treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing or palpitations , heart attack , low number
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritiximab ( 10 mg / ml ). the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixima contains sodium "). what riximsyo looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it is supplied
topotecan actavis contains the active substance topotecin . topotecaan actis is used to treat small cell lung cancer that has come back after chemotherapy or advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotan actalis treatment is combined with medicines called cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using topotocan activ . your blood cell counts may be too low . your doctor may need to adjust your dose of topotican actv . - if your doctor has told you that you have any kidney problems . your dose should be adjusted before using this medicine . warnings and risks talk to the doctor or nurse before using topsotecin actavis : - if severe kidney impairment .
the dose of topotecan actavis you receive will depend on the disease being treated and on results of blood tests carried out before treatment . the usual dose for treatment of adults small cell lung cancer : 1 . 5 mg per square metre of body surface area for 5 days . this treatment cycle will be repeated every three weeks . cervical cancer : 0 . 75 mg per sq metre of surface area , for 3 days . your doctor will decide on the dose you need for this treatmentcycle . in cervical cancer , the usual starting dose is 0 .75 mg per cubic metre of the body surface surface area once every 3 days , during
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . this may be due to your general condition ( local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea , bowel inflammation , neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , may effect up to 1 in 1 , 000 people ): difficulty in breathing , cough and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 and 2 to 8 , when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) or glucose
what topotecan actavis contains the active substance is topotecaan . each vial contains 1 mg or 4 mg topototecin ( as hydrochloride ). after reconstitution 1 ml contains 1 % of the active ingredient of topotican . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotan actis looks like and contents of the pack topottecan actalis is supplied in glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasterigmine works by blocking the enzymes that break down acetylCHoline : acetylchlorolinescerase and butyrylcholinesternase . by
do not take rivastigmine hexal - if you are allergic to rivasta ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if a previous skin reaction ( allergic contact dermatitis ) has been reported . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking this medicine . if you have : - irregular or slow heartbeat - an active stomach ulcer - difficulties in passing urine - seizures - asthma - severe respiratory
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg twice a day . your doctor may also increase your dose depending on your weight . your dose will depend on your response to this medicine . if you take more rivasta hexal than you should if you have taken more rvastigmin hexal in more than
like all medicines , this medicine can cause side effects , although not everybody gets them . you may get side effects more often when you start your medicine or when your dose is increased . the side effects listed below have been observed with rivastigmine hexal : very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ): anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each ritastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each capsule . each vit
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer , renal cell carcinoma or liver cancer that has spread to other organs . it can be given alone or in combination with a specific anticancer medicine containing sorafenib . what cabometyx does cabomety works by blocking the action of proteins called receptor tyrosine kinases ( rtks ). these proteins are involved in the development of high amounts in cancer cells . cabometx is used in adults to treat these cells .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety if you : - have high blood pressure - have or have had an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall - have diarrhoea - have had or have recently had significant bleeding from surgery within the last month - have undergone surgical procedures ( including dental surgery ) - have inflammatory bowel disease ( e . g . cro
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the correct dose of this medicine and will adjust your dose depending on your condition . your treatment may be stopped if you experience serious side effects . your dose will be adjusted according to your condition and your response to treatment . the recommended dose of cabometyx is 60 mg taken once a day . you should take cabometx for 2 hours before or 2 hours after taking cabomety . take the medicine at about the same time each day . swallow the tablet whole with a glass of water
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines . tell your doctor or pharmacist if your side effects get serious or if you notice any of the following serious side effects you may need urgent medical treatment : symptoms such as pain in the abdomen ( nausea ), ( feeling sick ), vomiting , constipation , fever , as these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ) which may lead to severe or uncontrollable bleeding . symptoms such : vomiting blood , black stolls , bloody urine
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg tablets : each tablet contains cabozatinib ( s ) and malates . each tablet of 20 mg cabozantsinib must be taken orally with or without food . cabobometyx 40 mg tablets: each tablet contain cabozutinib_( s ) or malate and should be taken with or with food . each tablets of 40 mg cabackantinibe must be swallowed whole with or just after food . the other ingredients are : cabometometyx 60 mg tablets tablet : caboz
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . pemrexed hospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine the best treatment for you . petrexedospira can be prescribed to you if
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir if you have or have had problems with your kidneys . before you receive pemetreted hospire , your doctor will check before each infusion that you have sufficient amounts
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area according to your height , weight and height and will adjust your dose depending on your general condition and on your response to treatment . based on your blood cell counts , your doctor may adjust the dose . your healthcare professional will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemet
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38Âºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash , burning or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expirability of the product does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . chemical and physical in - use stability of reconstitution and infusion solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . the reconstituuted solution should be administered immediately . parenteral medicines : if you notice discolouration prior to administration , this medicine should be
what pemetrexed hospira contains the active substance is pemetre . pemetrion hospira 100 mg : each vial contains 100 mg of pemetretrexed ( as pemetretted disodium hemipentahydrate ). pemetirion hospirite 500 mg : one vial of 500 mg contains 500 mg ofpemetrexED ( as Pemetrexede disodium emipenthydrate . pemrexedospira 1 , 000 mg : the active ingredient is petrexed . after reconstitution , the solution contains 25 mg / ml of pem
what ganfort is ganint contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work by interfering with a prostaglandin analogue . timolole belongs to medicines called beta - blockers . what ganf looks like and contents of the pack ganit is a clear , watery liquid that is injected into the eye by your eye . ganat is used in the back of the eye ( the front part of the coloured eye ) to treat glau
do not use ganfort eye drops : if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma or severe chronic obstructive bronchitis if you suffer from severe lung disease ( signs include wheeziness , difficulty in breathing , or long - standing cough ) if any of these apply to you , tell your doctor before using gannt . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have coronary heart disease ( symptoms include chest pain ,
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use glanfort your doctor will tell you how much ganf you need to use . how much to use the recommended dose is one drop in your eye once a day . before treatment , wash your hands . do not touch your head . 2 . gently squeeze the bottle . pull down your eyelid , which is closed by a small pocket . 3 . gently press the cap down on your eye during treatment . 4 . gently pull down the lid of your eye , until it is completely
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause some side effects . ganart ( multi - dose or single - dose ) can cause very common side effects ( affects more than 1 user in 10 ) the eye redness . common side effect ( affects 1 to 9 users in 100 ) the effect of ganat is : sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of the eye ( inflammation ), difficulty in seeing clearly , redness , itching of the eyelids , hair growing around
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . ganf is stable for up to 4 hours at room temperature ( up to 25 ). do this once a day . do this if you notice that the solution is discoloured or has particles in it . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ) timolol . each ml contains 5 mg of timolov maleate ( equivalent to 6 . 8 mg ). - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , clear , colourless to slightly brown solution for injection
gefitinib mylan contains the active substance gefitinib . this protein is designed to recognise and kill cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefitalinib melan if : you have any other lung problems . some lung problems may be serious . gefinib yourlan should not be used if you have problems with your liver . gifitin ib mylan should be used in children and adolescents under 18 years of age . other medicines and gefnitinib tell your doctor or pharmacist if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take the tablet with or without food . you may take antacids on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). take the tablets at least 1 hour before or 2 hours after food . gefnitinib melan can be taken with or just after food if you have trouble swallowing the tablet . if you take any other liquids , contact your doctor . the maximum recommended
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting parts of the body .
what gefitinib mylan contains - the active substance is gefetinib . each film - coated tablet contains 250 mg of gefinib - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . the tablet coating contains polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks like and
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can be a low red blood cell count ( anaemia ) which can be caused by lack of red blood infusion . reblozey is used : to treat anaemia in adults with mds who cannot be treated with red bloodcell transfusions ( erythropoietin therapies ) in patients with beta - thalassaemia . thalAss
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant , ask your doctor for advice before taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking rebluzyl if : you have thalassaemia ( a condition where the spleen removed ) you have had a blood clot , or you are undergoing hormone replacement therapy . you have a previous blood clot . your doctor may need to take preventive measures , including medicines to prevent a blood clot . you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you use reblozyl . reblzyl is given as an injection under the skin . the injections should be given at a maximum dose of 1 . 0 mg / kg of body weight . your dose will be adjusted by your doctor depending on your blood pressure . use in children and adolescents rebluzyl is used in the treatment of myelodysplastic syndromes . the maximum single dose is 1 . 75 mg /kg of bodyweight
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor immediately if you experience difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or in other parts of the body , with blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions with rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 hours or at room temperatures ( up or down ) for a maximum of 24 hours . from a microbiological point of view , the product should be used immediately . do away with rebl ozyl if it is
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution , each ml contains 50 mg of the active ingredient luspatecept . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack rebloxyl is a white to off - white powder . reblosyl 25 mg / 75 mg l
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer . it stops the growth and spread of cancer cells by blocking the growth or spread of new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor before taking fotiveda if you have high blood pressure . fotiva may lower your blood pressure , and your doctor may prescribe a medicine to lower your pressure . talk to a doctor before you take fotalda if your bloodpressure is not controlled with
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day for 21 days ( 7 days ). this means that you take 1 capsule of capsules once a morning , followed by 4 capsules once daily . if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . if severe side effects occur , stop fotovda therapy and contact your doctor . the usual daily dose of the fotive tablet is 890 mg once daily
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( this side effect can occur commonly , see section 2 ' warnings and precautions '). tell your doctor immediately if you experience high bloodpressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may need to adjust your dose of fotivda . high blood hypertension is not treated with a medicine to treat your high blood blood pressure . if you take more fotvda than you should if you accidentally take
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tivuzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890mg tivzanib , mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( for strong ammonia solution ), titanium dioxide , tartrazine aluminium lake ( e133 ), shellac , propyleneglycol ( ( for
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of elvitgravira emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil , an antitroviral medication called aucleotide reverse transcriptases inhibitor ( rtti ). stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus ( hiv
do not take stribild - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking stribil . during treatment , you should tell your doctor if you have taken any medicine containing tenofoviir disopyroxil . your doctor may adjust your dose of these medicines . alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , qu
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 years of age and older : the recommended dose is 35 mg once daily by mouth . your doctor may change the dose of your medicine depending on how you respond to the treatment . your dose may be adjusted by your doctor , if necessary , by taking medicines called oral supplements ( antacids or laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ). take the tablets at least 4 hours before or at least one hour after taking stribild . if you take
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hiva disease itself or by the medicines themselves ( see section " serious side effects "). tell your doctor immediately if you experience lactic acid
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabrine , 245 mg tenofvir disopicroxil and 300 mg ten ofovir desoproxel fumarate , 136 mg tenorovir . the other ingredients are : tablet core : croscarmellose sodium , hydroxypropyl cellulose , lactose
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zyPrexa . zypitxa has not been studied in elderly patients with dementia . it may have serious side effects
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be swallowed with some water . zkyprexa can be taken with or without food . you can take it with or just after a meal . the usual dose is one 5 mg tablet once a day . your doctor may increase your dose to one 20 mg tablet twice a day depending on your symptoms . swallow the tablet whole with some food . do not chew or crush the tablet . you should take your zypxa tablets with or shortly after food . it is important that
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( a side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . zyprexa should not be used if you notice that the solution is not clear or contains particles . do this to avoid evaporation . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zyPrexa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg . the other ingredients are : tablet core : lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypxa tablet strengths are : - zy prexa 2 . 4 mg , 6 mg , 7 . 75
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that attaches to a target in the body . this target is a protein that is designed to bind to a specific target in your body . when a target is attached to another protein , it can cause bone loss in osteoporosis . treatment with prolia helps to make bone stronger and keeps it free of deposits of oestrogen that can form over time . if your bones are thin and fragile , osteopoosis may occur . osteoporeosis is caused by the lack of testosterone and glucocorticoids .
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , or if you feel any of them apply to your child , tell your doctor straight away . if prolia is not recommended for your child : if you develop a skin infection with symptoms such as a swollen , red area of skin , usually in the leg , which feels hot , tender ,
what prolia is prolia contains one pre - filled syringe ( 60 ml ) that will be given to you in a hospital or clinic . it is given every 6 weeks as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . you can inject prolia yourself or with a caregiver . it may be given at any time of the week , including up to 6 weeks after the last injection . your doctor will tell you how long you should continue to receive prolia . if you use more prolia than you should if you have injected more prolias than you have
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you develop skin infections ( cellulitis ). if you have any of these symptoms while taking prolium : - swollen , red area of skin , usually in the leg , which feels hot and tender . - symptoms may include fever . stop using prolia if you experience pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), as these could be signs of bone
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . before you use your pre - filled syringe , it should be stored at room temperature ( not above 25 ) for a single period of maximum three months . after the injection , it may be stored either at room temperatures ( not below 25 ) or below 30 . do away with the vials and dispose of them after this
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg of denosumaab , corresponding to 60 mg / ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirux is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection with the hepatitis a virus causes the liver to become swollen and inflamed . the virus is caused by the virus in faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . if you feel sick , have a fever , aches and pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to person .
do not use ambirix - if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine . - if any of these apply to you , tell your doctor straight away . warnings and precautions talk to your doctor or nurse before using ambirux : - if : you have hepatitis a or hepatitis b diseases - if your child has a severe infection with a high temperature . the vaccine may be given to protect against
your doctor or nurse will give you ambirix as an injection into a muscle ( usually in the upper arm ). ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . you should usually receive the first injection at least six months after the second injection . if you are between 6 and 12 months of age , you should receive the second injections between 6 months and 12 years after the first one . extra doses may be given to prevent future booster dosing . it is important that you receive at least two
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure , or loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired irritable pain or redness where
what ambirix contains 26 the active substances are hepatitis a virus ( 1 , 720 micrograms / ml ) and elisa units ( hepatitis b surface antigen ). the other ingredients are 20 microgram ( 0 . 5 ml ) human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white , slightly milky liquid .
what bexsero is bex serumo is a meningococcal group b vaccine . what bex sero is used for bexestero is given to adults , adolescents and children aged 2 years and older . it is a type of disease caused by the neisseria meningitidis group b bacteria . these bacteria cause infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex serumo if : you have a severe infection with a high temperature . vaccination should be postponed until you have recovered from a minor infection such as a cold . vaccination of patients with haemophilia a if you have any other problem that may prevent your blood from clotting properly . you are taking blood thinners ( anticoagulants ) as part of treatment for the immune system ( eculizumab ). if any of these
your doctor or nurse will give you bexsero at the recommended dose . the recommended doses are : 5 micrograms injected into the muscle of the thigh or upper arm . injections given at the dose recommended by your doctor , your doctor will decide how many injections you need . children from 2 to 5 years of age three injections of the vaccine will be given . an additional injection ( booster ) will be administered at the interval between injections . the first injection will be made at 2 - 3 weeks intervals . the intervalbetween injections will be 1 month . the second injection will make up for 2 months . your doctor may decide to give
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness of the area of the injected skin at site of the injection . if any of these side effects occur , stop using this vaccine and tell a doctor straightaway . common ( might affect up to 1 in every 10 people )
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitis group b noada protein 1 and 2 3 microgram s recombinant neoisseria meingitidas group b fhbp fusion protein 2 and 3 micrograms 50 microgram s recombinating neissia meningitsidis groupb fhbhbp fusionprotein 1 , 3 , 4 , 5 , 10 microgramS recombinant dna technology 2 the other ingredients are : aluminium hyd
nitisinone mdk contains the active substance nitisinon . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children aged 1 year and above . due to this disease your body does not make enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisinnone helps to reduce the amount of tyrosinine and the harmful substances that can be produced . this means that tyrosrine is eliminated from the body by low tyrosines and phenylalanine ( another amino acid ).
do not take nitisinone mdk - if you are allergic to nitisinfone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone md k may affect the eyes , especially during nitisine treatment . if you get red eyes , tell your doctor immediately . your doctor may recommend an eye examination . if any of these apply to you , tell the doctor . eye problems due to inadequate dietary control may occur ( see section 4 ). your doctor will monitor you closely during the treatment
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule ( 1 mg ) for every kg of body weight . the dose may be increased to 20 capsules ( 1g ) once daily . in this patient population , the dose is based on body weight and should be taken once daily at about the same time each day . swallow the capsules whole with a small amount of water or formula diet . if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 2 8 . store at a temperature not above 25 . do away with the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitisinnone md k 2 mg : each capsule contains 2 mg nitisine . nisinone MDk 5 mg : one capsule contains 5 mg nisine . each capsule of nitisginone mdks 10 mg : two capsules contain 10 mg ninone . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisinsone mdK looks like and contents of the pack nitisinfone mdky capsules are 15 . 7 mm long , hard
the name of the medicine is docetaxel accord . docetacel accord belongs to the group of anti - cancer medicines called taxoids . doceteaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer : docetailel could be administered either alone or in combination with doxorubicin , or trastuzumab , or capecitabine . - for early breast cancer with or without lymph node
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if white blood cells are low - if your liver is not working properly - if there is a severe liver disease warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . in case of white blood cell disturbances , you may experience fever and infections . tell your doctor immediately if you experience abdominal pain , tender
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( mÂ² ) and will determine the dose you should receive . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your physician may change the dose and frequency of dosing depending on the results of your blood tests and yourgeneral condition
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be higher when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( very common , may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the vial should be used immediately after dilution . the medicine should be transferred from the infusion bag to the infusion vial and used within 6 hours ( 25 hours ). for infusion , the infusion solution should be stored in non - pvc bags for 48 hours ( 2 to 8 ). do not freeze . the
what docetaxel accord contains - the active substance is docetacel . each ml of concentrate for solution for infusion contains 20 mg docetamineel . 1 ml of the concentrate contains 20mg docetaceel . 4 ml of solution for injection contains 80 mg docel . 8 ml of solvent for solutionfor infusion contains 160 mg docotaxel . - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetAXel accord is a concentrate for solvent for infusion "), citric acid anhydrated ( see also section 2 ) and citric acidic anhyd
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . this medicinal product helps to control the behaviour of impulsive or hyperactive people . this medication is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults whose current stimulation is not controlling adhd symptoms . the medicine is used together with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intuniv is used in adults 38 years of age and older who are not controlling their condition . intuiv is intended for use in adults who are still developing adhd .
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you may have fainted recently if you had thoughts or feelings of suicide or any other psychiatric conditions ( withdrawal symptoms ). increased heart rate or highblood pressure have been reported in patients taking this type of medicine . your doctor may need to adjust your dose of this medication to reduce the risk of these problems . children
your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased depending on your response to treatment . the dose will gradually be increased over the course of 1 day . the starting dose for treatment will usually be 0 . 05 mg / kg of bodyweight once daily , with a maintenance dose of 0 . 12 mg / m2 bodyweight twice daily
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , talk to your doctor straight away . your doctor may need to change your dose of your medicine . serious side effects tell your doctor immediately if you notice any of the following serious side side effects : feeling drowsy ( feeling dizzy ), hypotension ( slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect with high blood pressure . symptoms include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within one month after first opening of blister pack . do this to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each tablet contains 1 mg of guanFacine . each 2 mg prolonged - release tablet contains guanfuine hydro chloride . each 3 mg prolonged release tablet releases guanjuine . the 4 mg prolonged prolonged -release tablet contains 4 mg of Guanfacin . the other ingredients are : hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone type a , microcrystalline cellulose , silica colloidal anhydrous , sodium
ecalta contains the active substance anidulafungin and is used in adults ( from 1 to 18 years old ) to treat fungal infection in the blood or other internal organs ( invasive candidiasis ). the infection is caused by fungal cells called candida . ecalta belongs to a group of medicines called echinocandins . these medicines prevent serious fungal infections from spreading to other organs by preventing the formation of fungal cell walls . ecalda is indicated in adults because it is thought that fungalcells have incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra . your doctor will check your liver function . if you have liver problems , your doctor may decide to delay your treatment or give you anaesthetics . your treatment with ecaltera may need to be slowed down or stopped . if an allergic reaction occurs , such as itching , wheezing , or blotchy skin ,
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . adults ( aged 1 to 18 years ) the recommended starting dose is 3 . 0 mg / 200 mg given twice a week , given once in the morning and once in evening , given at a dose of 1 . 5 mg / day . the dose may be increased or decreased depending on the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) over a period of 1 to 5 minutes . the loading dose may vary depending on how you respond to the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ecalta : serious and potentially life - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash , have been reported in patients taking ecaltara . serious side effects including convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheezezing , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expirability date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 . if the infusion solution is not used within 25 hours it should be stored in a refrigerated
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of aniduafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( human cogulation factor iii ). factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is missing or not working properly . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v ii .
do not use adynovi - if you are allergic to rurioctocog alfa pegol , octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to any of these ingredients . warnings and precautions talk to your doctor or pharmacist before using adynov : - if the child has had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyno . allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing ,
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia a . your doctor will decide how much adynov you need and will determine the dose you need . treatment of bleeding the recommended dose of adynoc is one tablet once a day . the replacement therapy may be continued . adynova is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding your doctor may prescribe adyno 40 mg or 50 mg tablets once a week for 2 weeks . to help prevent bleeding , your
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if you experience severe symptoms such as difficulty in breath , wheeezing or tightness around the chest ( a feeling ofbeing unwell ), dizziness or loss of awareness , contact your doctor immediately
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . do this medicine if it is not used within 3 months or if it has been stored at a temperature not above 30 for a longer
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa pepegol . the solvent vial provides 5 ml sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydration , tris ( hydroxymethyl ) aminomethane , polysorb
rekovelle contains follitropin delta , a follicle stimulating hormone , which belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs , in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they are produced by the ovaries of many egg sacs .
do not use this medicine if any of the following apply to you or your child : - if you have your fertility problems - if your child is allergic to follicle stimulating hormone or any of those other ingredients of this medicine ( listed in section 6 ) - if the tumour in your uterus ( ovaries , breasts , pituitary gland or hypothalamus ) has enlarged ovaries - if there are cysts on your ovaries ( polycystic ovarian disease ) - bleeding from the vagina - if a woman reaches an early menopause - if any member of your family has malformations of the sexual organs ( which may
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you at the start of your first treatment cycle . your doctor will also prescribe anti - MÃ¼llerian hormone to stimulate your ovaries to produce more stimulation with gonadotropins . the dose will depend on the amount of hormones in your blood . your dose will also be calculated from your body weight . your physician will take a blood sample during the last 12 months to work out the dose you need . the total duration of treatment depends on your bodyweight .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen . nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation syndrome ) pelvic pain and discomfort ( ovarian origin tiredness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the vials in the original package in order to protect from light . after reconstitution , the solution may be stored at room temperature ( up to 25 ) for up to 3 days , but not above 3 days . after this period , the product should be used within 28 days or disposed of . do away with
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitopin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient follitopein deltain each millilitere of solution ( corresponding to 0 . 38 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahyd rate , concentrated phosphoric acid , sodium hydroxide and water
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptka contains flutic asone furaate 92 mg and vilterol 22 mg . each inhale of fluticasa furoates 184 mg and / or vilancerol 22mg is equivalent to 92 / 22 mg of the active substances . chronic obstructive pulmonary disease ( copd ) in adults and adolescents ( 12 years of age and older ) weighing 184 kg or more . the 22 / 22 inhalation dose is the same as for adults and for adolescents
do not take ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ellipta . ellipta should not be used if you have liver disease . the following side effects may occur if you suffer from moderate or severe liver disease : the lower strength of revinty ellipta 92 / 22 mg / m2 tablet is used to treat : heart problems , high blood pressure , tuberculosis ( tb ) of the lung , or any long standing or untreated infections
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the usual dose for asthma is one inhalation twice a day ( one inhalant each day ). this is one dose in the morning and one inhalate in the evening . the dose is one tablet in the afternoon . for asthma the dose should not exceed one inhalations twice a morning ( one tablet each day ) and one tablet once a day . for severe asthma the higher strength inhaler should not be used . the usual starting dose is two inhalations once a morning , one
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you have any of the following symptoms while taking ellipta stop taking this medicine and seek medical help immediately : skin rash , hives , redness swelling , mainly of the face or mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties immediate breathing problems stop taking revinty ellipta and seek immediate medical help if your
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each inhalation provides 92 micrograms of flutic asone fiformate and 22 microgramms of vilancerol ( as trifenatate ). each 184 microgramgrams inhalation delivers 184 microgms of flilitasonefuroate , 22 micrograms of vilenatine . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is for oral use "), magnesium stearate . what revintsey ellipta
atripla contains three active substances that control human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( rtrti ) and tenofovir , aucleotide reverse transcriptatase inhibitor . these active substances are used in combination with antiretroviral medicines to control the level of an enzyme ( reverse transcriptasing ) in the virus . atriplba is a treatment for human immunosuppression virus ( also
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . take atripla on an empty stomach ( 1 to 2 hours apart ). some side effects may be more common , such as dizziness and drowsiness . if you take more atripola than you should if you accidentally take too many atripa tablets , contact your doctor immediately . if possible , take your tablets with you . you may experience dizziness or drowsy when taking atrila . if any
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) may occur rarely ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg efavenirenz and 200 mg emtrititabin , respectively 245 mg tenofoviir disopicroxil ( as fumarate ). the other ingredients are : tablet core : croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "
orgalutran contains ganirelix which belongs to a group of medicines known as anti - gonadotrophin . it is a synthetic version of the natural gonadodotrophine releasing hormone ( gnrh ), which is produced by the body . release of gonadotroprophins is the natural follicle stimulating hormone . gonadots help to control the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells from the sacs and follicles from the ovary . orgalutra may be used in
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ) or any other gonadotropin - releasing hormone , such as a gnrh analogue . - if your child has a moderate or severe kidney or liver disease . - you are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . if you develop an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is given to you by a doctor or nurse who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), corifollitropin on day 2 or day 2 of each 3 cycle . orgdalutran will be injected under the skin ( subcutaneously ) on days 5 and 6 of each cycle . your doctor will decide how many cycles you should receive orgaluit
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a side effect , tell your doctor immediately . very common ( may affect more than 1 in 10 people ): local skin reactions ( including redness and swelling ). the local reaction usually disappears within 4 hours . uncommon ( may affects up to 1 in 100 people ): headache nausea ( malaise ). very rare ( may affecting up to1 in 10 , 000 people ): allergic reactions such as rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat that may cause difficulty in breathing or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . syringes should be clear , colour - free solutions . do away with any unused syringe . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( for the ph ) and sodium hydroxide ( for acetic acids ). what orgaluitran looks like and contents of the pack orgaluchran is a clear , colourless aqueous solution for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in packs containing 1 or 5 vials . not all pack sizes may be marketed .
what blitzima is blitzima contains the active substance rituximab , a " monoclonal antibody ". it sticks to a target in a type of white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , the cell dies . what blitzima can be used for blitzima has been prescribed for the treatment of two different conditions : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue ( part of the immune system ) that affects a type a white blood type called b - locytes . blitzima may be given alone or
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe active infection . - if he / she has a weak immune system . - warnings and precautions talk to your doctor or pharmacist before using blitzima if your baby has severe heart failure or severe uncontrolled heart disease . - granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris ( see section " other medicines and blitzima
how blitzima is given your doctor will decide how much blitzima you will receive and for how long . always use this treatment exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor may decide to change the dose of this medicine if you experience any side effects . how blitzima will be given blitzima comes as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . for non - hodgkin ' s lymphoma
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy or runny nose , vomiting , flushing or palpitations , heart attack , low number
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritiximab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is available in 2 packs containing 50 ml or 1 pack containing 50ml . not all pack sizes may be
what roactemra is roactemnra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain . this target is found on the surface of cells that cause inflammation in your body . roactenra can help prevent symptoms such as pain and swelling in your joints . roactoremra reduces the damage to the cartilage and bone in your bones caused by the disease . what roactemetra is used for roactemira is indicated for the treatment of moderate to severe active rheumatoid arthritis
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash . these reactions are usually mild and go away within a few days . tell your doctor immediately if you feel unwell . warnings and precautions talk to your doctor or nurse before using roactemara : if you develop any of
the doctor or nurse will give you roactemra by a drip into a vein ( intravenous infusion ). your doctor or a nurse will decide on the dose you need . the intravenous infusion will be given over a period of one hour . the treatment will be started by a doctor or another healthcare professional . the recommended dose is roactema 8 mg / kg body weight once a day for 4 weeks . your doctor will decide how many weeks you need to take roacteme 8 mg per kg bodyweight once a week for 8 weeks . the usual dose is 30 mg /kg body weight twice a week . your dose
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the post marketing setting in patients treated with 3 mg of roactemnra : serious side effects ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity ( may occur in up to1 in
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the carton and the vial after exp . the expirability refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 mg . each 10 ml vials contains 200 mg of of tocelizumumab ( 20 mg ). each 20 ml vray contains 400 mg of the active substances of tocizumabe ( 20mg ). the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack roactrem
what onbrez breezhaler is onbrex breez inhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . what onbreez breezcheler is used for onbrezer is used to treat breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine works by relaxing these muscles in your lungs , making it easier for air to get in and out of
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using onbrezer : - if the patient has heart problems , epilepsy , thyroid gland problems , thyrotoxicosis ( diabetes ). treatment with on brez breezerhaler should be stopped immediately if you get tightness of the chest , coughing , whe
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( one 300 microgram ) day . your doctor will tell you how many capsules to use and how long you should continue the treatment . you should use your inhaler at least 24 hours after you last used it . onbrez breezhaler is for inhalation use . you can use an inhaler and capsules ( in blisters ) with the medicine provided as inhalation powder . the onbreez breez inhaler inhaler contains
what onbrez breezhaler contains - each onbrex breez inhaler 150 micrograms inhaler contains 150 microlitres of indacaterol ( as indacathol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronzhalER 300 microgramS inhaler 300 microlitre inhaler includes 300 micrometres of of indiacaterol , as indiacatholmaleate . - the ingredients are made of lactoseand the capsule contains gelatin . what onbreez breezeler looks like and contents of
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events (
do not take clopidogrel hcs - if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if severe liver disease is a possibility . if any of these apply to you , tell your doctor before taking clopridogrel clcs . warnings and precautions if any situation you are at risk of bleeding suchas - if any member of your family has a medicalcondition that puts you at risk for
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). the other ingredients are ( see section 2 ' clopide hcs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc ,
feccroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are antibiotics that help to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously fought with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have ever had other antibiotics ( e . g . cephalosporins ). if your doctor has told you that you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if this applies to you , tell your doctor straight away . if you experience severe skin pe
this medicine is given by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 weeks . your doctor will decide how long fetcroja treatment will last . your dose will be decided by your doctor . your infection will be treated as soon as possible . you should not feel any pain during the fetcroJA infusion . it is recommended that you continue to receive fetcrora for as long as your doctor prescribes it for you . if you have kidney problems tell your doctor if you are having kidney problems . if your dose of fetcrofa is reduced , your doctor may increase
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . this reaction may lead to diarrhoea , stools , blood or mucus . treatment may be stopped or medicines may slow bowel movement . other side effects if you get any of these side effects talk to your doctor or pharmacist . other possible side effects : common
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefingerocol . - the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrofa is a white to off - white powder for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomatinous menenitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is prepared by biotechnology and is used in adults . lymphoma tumour cell growth is not spread to other organs .
do not take depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking depocyte . - if your child has a meningeal infection . - severe neurological side effects when taking depocytes . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking depoly and contact your doctor immediately . - taking any dexamethasone tablets may increase the risk of unwanted
before starting treatment with depocyte , your doctor will decide on the appropriate dose for you . if you have cancer , your surgeon will decide the correct dose . depocyte will be given to you by a doctor or nurse trained in the use of the product in the lumber sac . depocytes will be prepared and given to your child by a healthcare professional . the recommended dose of depocyte is 1 vial of 5 mg dexamethasone 5 mg / kg . each depocyte dose will be monitored by your doctor to detect any side effects . the dose of the medicine will be calculated according to the body surface area ( mÂ²
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ): very rare cases ( affects fewer than 1 in 10 users ) not known ( frequency cannot be estimated from the available data ): frequency not known : frequency cannot yet be estimated based on the available
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expirability of depocyte is stated at the end of the leaflet and on each vial after exp : the expira date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte may be stored at room temperature ( up to 25 ) for up to 4 weeks in the outer carton . do this if you notice that the solution is discoloured or contains
what depocyte contains - the active substance is cytarabine . one ml of suspension contains 10 mg cytarabiline . each vial of 5 ml solution contains 50 mg cytabine ( as cholesterol , triolein ). - the other ingredients are dioleoylphosphatidylcholine , dipalmitoylophosphatideylglycerol , sodium chloride , water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection ( solution for infusion ) in a vial . depocyte 5 ml is available in packs containing one vial
what bemrist breezhaler is bemist breez inhaler contains two active substances called indacaterol and mometasone furoate . indacasterol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to an important group of medicine called corticosteroids ( also called steroids ). corticoplastics reduce the swelling and irritation ( inflammation ) in the small airways in the lung , making breathing problems worse . cort
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before using bemist breez inhaler if you think you may be allergic . - if your doctor has told you that you have heart problems . - tell your physician if you have an irregular or fast heartbeat . - you have thyroid gland problems . you have diabetes , high blood sugar , seizures or low level of potassium in your blood . - have severe
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . you should take the medicine at the same time each day . this will help you to remember to use it . it will also help you remember to take it . if your asthma is not being controlled well enough , your symptoms may get worse . how bemist breez inhaler is for inhalation use . be mrist breezezhalzer is for use as an inhaler and capsules . the medicine is inhaled through
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to 1 in 100 people ): swelling mainly of the upper tongue , the lips , face or throat ( signs for angioedema ). other side effects other sideeffects include the following listed below : very commonly ( may affects more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 mg / 62 . 5 mg capsules each capsule contains 173 mg indacate , 150 mg indaconaterol and 80 mg mometsone furuate . the dose is adjusted by your doctor to allow the dose to be adequately absorbed by the mouthpiece of the inhaler . each capsule also contains 125 mg indaceaterol , 62 . 75 mg mhometason furoates . bemmrist breezyhal
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atheroarthrombotic events ( such as stroke , heart attack , or death ).
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . warnings and precautions before taking zylltt , tell your doctor if any of these apply to you . if any part of you is not sure , talk to your doctor or pharmacist before taking this medicine . if : you have bleeding such a medicalcondition that puts you at risk of internal bleeding ( such as - a stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily dose is one one 75
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyllT
lamivudine teva contains the active substance lamivudrine . lamivuxine tella is used to treat long term ( chronic ) hepatitis b infection in adults . lamivaludineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic ") infection can lead to liver damage . lamlivudine precludes the damage to the liver and so reduces the risk of compensated liver disease . treatment with
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamivuine tevas , like other similar medicines , can cause serious side effects , including liver disease , hepatitis c . if you become overweight , your doctor may need to change your dose . you will have blood tests periodically during treatment with your medication ( see section 4 " warnings and risks "). if you take more lamivuxine tella than you should if you accidentally take too many tablets , or if someone else accidentally takes your tablets
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you complete the full course of your infection and to keep your illness under control . you should continue to take lamivodine tella every day until your doctor tells you otherwise . if you cannot take lamvudineteva as your prescribed dose , you may need to take another medicine . lamivuda teva can be taken with or without food . if lamivustine is taken with
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the most serious side effects reported during therapy with ' hepatitis b ' have been : side effects that have been observed during lamivudaine clinical trials include tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , and increases in liver enzymes . these are signs that the liver is not working properly . these may be signs that your muscles are not working normally . allergic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after first opening . do this if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivuda . each film - coated tablet contains 100 mg of lamivuine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , debossed
nespo is an anti - anaemic ( means that your anaemia is not caused by any other medicine ). anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by interfering with the natural hormone erythropoietin . erythroietin works by blocking the growth of your kidneys and so makes your bone marrow produce more red bloodcells . it is also given to you by your doctor to reduce the production of darbepoetin alfa . chronic renal failure ( symptomatic anaemia ) chronic renal fail
do not use nespo if you have high blood pressure or are taking other medicines . if you are allergic to nespos ( darbepoetin alfa ) or r - huepo . warnings and precautions talk to your doctor or pharmacist before using nesp if you suffer from high bloodpressure . you should not use medicines to treat sickle cell anaemia ( fits ), epileptic fits ( seizures ), convulsions or seizures . if your doctor has told you that you have liver disease , you should use drugs to treat anaemia . if any of the above apply to you , tell your
your doctor will carry out blood tests before you start nespo . your doctor will check your haemoglobin level regularly . the usual starting dose is 10 mg . if you have a haemogl level of 10 mg or less , your doctor may increase your dose to a maximum of 10mg . your dose may be increased to a minimum of 12 mg . the pre - filled syringe is for injection into a vein . in patients with chronic renal failure , a single injection is given under the skin or into a veins ( intravenous ). your doctor or nurse will check for your anaemia and will adjust your dose of nes
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : very common ( may affect more than 471 people ) uncommon ( may affects up to 10 in 100 people ) high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon : ( may effect up to 1 in 100 , 000 people ) blood clots ( thrombosis ) pain in the area injected rash , redness and areas of the skin rare : ( might affect up to1 in 10 , 000 , 000 patients ) serious allergic reactions sudden life - threatening allergic
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the original package in order to protect from light . after first opening , nespos may be stored at room temperature ( up to 30 ) for a maximum of 7 days . do this at the end of this period . do away with nespen before you use it . medicines should not be disposed
what nespo contains the active substance is darbepoetin alfa . each ml of solution contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu of the active substances darbasic and alfa - 2b . the other ingredients are sodium phosphate monobasic , sodium phosphate dibasic ( e415 ), sodium chloride , polysorbate 80 and water for injections . what nespos looks like and contents of the pack nespi is a clear , colourless to slightly pearly liquid
macugen is a solution for the eye that contains the active substance pegaptanib . this medicine prevents abnormal formation of new blood vessels in the eye . macugen is used for the treatment of adults with macular degeneration . in this disease , vision loss is caused by damage to a part of the retina called the macula . macula is the thin layer at the back of the eye called the retina . macular is the macular layer that lines the front of the lens . maculas are the thin layers at the front part of your eye . the maculula is one of the layers that lines your eye (
do not use macugen : if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have had an infection or bleeding in the eye , stop using macug injection and contact your doctor immediately . if any of these apply to you , tell your doctor straight away . if the following symptoms occur , contact your eye doctor immediately : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision ,
mugen will be given to you by a doctor or nurse . injections of macugen will usually be given by a single injection into your eye . the recommended dose is 6 to 9 ml . the injection will be injected into the vitreous part of your eye ( the front part of the eye ). macugen is given in combination with antibiotic eye drops . your doctor will clean your eye and give you some local anaesthetic (umbing medicine ) to prevent any pain you may have after the injection . if you are allergic to antibiotic eyedrops , your doctor may decide to temporarily stop antibiotic treatment to prevent eye infection . if macugen volume
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms may include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported following macugen treatment . the symptoms are described in section 2 . if you experience any of these symptoms , contact your doctor immediately . other side effects very
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the medicine in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection is a single dose pack supplied in a pouch . each pack contains a pre -filled syringe of 0
kipivance contains the active substance palifermin , which is produced by biotechnology in the plant called escherichia coli . palifermine works by stopping the growth of epithelial cells in the mouth and digestive tract and by blocking their growth in the tissues below the skin . palfermin is used to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as a side effect that can be treated with treatments for your blood cancer . if your bloodcancer is not being treated with chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( a procedure
do not take kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents kepivalance is not recommended for use in children and teenagers under 18 years of age . other medicines and kepvelance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . kepiverance may affect the way heparin works . tell your pharmacist , pharmaceutist
how kepivance is given the doctor will decide on the dose you need and how long you need to receive cancer treatment . the usual dose of kepvance is 60 mg . the recommended dose of one kilogram of body weight is given as an intravenous injection into a vein . how kepvelance is administered kepovance is usually given once every three days . if you are having chemotherapy or radiotherapy , you will be given three doses of chemotherapy or radiationotherapy at least 24 to 48 hours after the chemotherapy . if your doctor decides that radiotherapy is inappropriate , you may be given two doses of radi
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and in levels of digestive enzymes in the blood . most of these effects occur within the
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepiverance looks like and contents of the pack kepiveance is a white powder supplied in a vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcit which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconalcate accordphara is used in adults to treat secondary hyperparathyroidism ( secondary ) in patients with serious kidney disease who are not on dialysis and whose thyroid gland is not working properly . ciclacalcancet accordpharma is used : to treat
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will check your blood calcium levels regularly before and during treatment with cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking cinicalcvet accordphara : - if any of these apply to you , tell your doctor before taking this medicine . - if : you have ever had seizures ( fits , conv
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . cinnacalcitpharma should be taken twice a day , with or shortly after meals . the tablets should be swallowed whole with water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual starting dose of cinacealcordpharma is 30 mg once a day ( one tablet in the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures ( these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat which may cause difficulty in swallowing or breathing ( angioedema ). these side effects are very common ( may affect more than 1 in 10 people ) and may include nausea and vomiting . if you notice any of these side effect , contact your physician immediately . common (
what cinacalcet accordpharma contains - the active substance is cinacealc . each film - coated tablet contains 30 mg , 60 mg or 90 mg of ciniacalcate ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcelcet cordpharma looks like and contents of the pack cin
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformins and biguanides . they work together to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflozin ) or
do not take jentadueto : - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has severely reduced kidney function . - if he / she has uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . - lactic acidosis ( see section " risk of lacticacidosis " below ). - ketoacidosis . keto acidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jentadueto is one tablet once a day . you should take this dose regularly , preferably at the same time each day . if you currently take metformin or individual tablets of linagliptin or metformatin , you should continue to take this this medicine until your doctor tells you otherwise . if this medicine does not work well enough to control an upset stomach , you may need to take 5 mg linaglptin or 2 , 000 mg metformina hydrochlor
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglycasemia is very rare ( may affect up to 1 in 10 , 000 people ). this side effect may occur with jentadoeto plus sulphonylurea or with the combination jentadaeto plus insulin .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the original package in order to protect from light . do this medicine if you notice any visible sign of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformine hydrochloric acid . - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . what jentadaeto looks like and contents of the pack jentado
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older who are already taking hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants is used in combination with hiv medications to treat adults and adolescents aged 12 months and older infected by hiv . it is not recommended that you take hiv medicine together with edurent . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent . if you take any of these : - the following medicines : - carbamazepine , oxcarbazepine or phenobarbital , or phenytoin ( medicines used to treat some bacterial infections ( such as tuberculosis ) - omeprazole , esomeprazole or lansoprazole - pantoprazoles or rabeprazoles ( pro
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 18 years and over ) edurant is not recommended for use in children and adolescents . the recommended dose is one tablet once a day . do not take more than one tablet in the morning . do this if you have the impression that the effect of edurants is too strong or too weak . rifabutin is a medicine used to treat some bacterial infections . if you take more edurent than you should if you accidentally take more rifaberutin than
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or problems with your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpaline hydrochloride . each film - coated tablet of edurants contains rrilpiviraine hydro chloride equivalent to 25 mg rilpanirine ( as hydrochloric acid ). the film - coating contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film coating contains : lactosemonohydrate , hypromellose 2910 ( e464 ),
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . type 2abetes is when your body does not make enough insulin to control the level of sugar in your blood . your body can also make too much insulin , which can cause rosigslitazONE and met formin to work too well together . your doctor will check whether the insulin is working properly and will adjust your blood sugar if necessary . avandamvet is also used as a sulphonylurea ( a type of diabetes )
follow all your doctor ' s instructions carefully . check with your doctor or pharmacist if you are not sure . your doctor may need to change your dose of avandamet . do not take avandamanet if you : are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) have had a heart attack have severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting )
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is 1 tablet a day . if you weigh 8 kg or more , the maximum dose is 4 mg rosciglitrazone ( corresponding to 1000mg metforma ). thisdose is 2 tablets a day , with food . swallow the tablet whole with a glass of water . do not crush or chew the tablet . avandamanet can be taken with or without food
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet can include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), with difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and seek medical advice straight away . lactic acidosis ( a build - up of lacticacid ) can occur in some patients , particularly if the medicine is being used to treat a condition in which the acid builds up in the blood ( lactic acidsosis is a common
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any particles in the solution or if the tablets are discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets contain 1 mg rosigllitazon ( 500 mg ) metforma . each tablet contains 2 mg rospiglitasone ( 500mg metforman ). each tablet also contains 2 tablets rosiklitazione ( 1000 mg metformatin ). each film - coated tablet contains 4 mg rosciglitazaone ( 1000mg met formin ). the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose mon
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopIDogrel has been shown to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events ( such as stroke
do not take clopidogrel mylan 31 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before takingclopidigrel myl : if you think you may be at an increased risk of bleeding such a medicalcondition that puts you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopipidogl ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopideogrel Mylan contains hydrogenatedcastor oil '), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc , macrogl
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thromboocytopenia ), in adults , in a medical procedure to reduce bleeding . it works by reducing the number of platelets in the blood . platelets are blood cells that are needed in theblood to clot and prevent bleeding .
do not use doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks that you may have a risk of blood clots in the veins or arteries . warnings and precautions talk to your doctor or pharmacist before using doptelelet : if you have a history of bloodclots . if you think that you have blood clumps , ask your doctor . if your family has cancer . if the contraceptive birth control pill has been changed or hormone replacement therapy has been recently used . if a child has had surgery
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . your dose of dopteol may be increased to 20 mg , 40 mg or 60 mg once a week . your physician may increase the dose to 5 mg once daily depending on the severity of your platelet counts . if you take more doptelets than you should if you accidentally take too many tablets , contact your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg of avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ).
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by helping to open the heart arteries , thus increasing heart rate and the muscles of the heart . rapiscan is used for the purpose of performing a type of heart scan called ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken to measure the muscles in the heart using a readmill . a scan contains a small amount of radiopharma which is injected into the body through a vein . this medicine is given to you by your doctor or nurse to make images
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or a pacemaker that does not work properly . if you experience chest pain ( unstable angina ) during treatment , especially if you are suffering from low blood pressure ( hypotension ), heart failure or if you drink alcohol excessively . if your doctor thinks that you may be allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before taking rapiscen if any of these apply to you : if you : have a recent serious heart
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of one hour . the recommended dose is 400 mg given as a 5 ml solution the injection will be administered over a minimum of 5 minutes . the dose may be given over a maximum of 10 minutes depending on your weight . your doctor will also give you an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection over a total of 5 hours . this is because rapiscan contains a radioactive substance (
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects usually occur within a few days of the rapiscin injection and usually disappear within 30 days without any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be due to damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . rapiscans may cause a stroke or cerebrovascular accident . if you have
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . pde 5 works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction ( impotence ), a condition where a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have not taken any of these medicines , tell your doctor . - if the doctor has prescribed nitric oxide donors such as amyl nitrite , which may lead to an increased risk of a dangerous drop in yourblood pressure . - when you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once a day . viagra film - coated tablets are for oral use . viag orodispersible tablets are also for oral . swallow the tablets whole with a glass of water . do not crush or chew the tablets . viaga can be taken with or without food . taking viagra with food will help you to get an erection . it is important that you continue to take viagra until you are sexually stimulated . if you take more viagra than you should if
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . if any of the side side effects gets serious , stop taking viagra and seek medical help immediately . an allergic reaction is uncommon ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness , swelling of the eyelids , face , lips or throat . if you experience chest pains , you may be in a semi - sitting position and you may need to take nitrates to relieve your chest pain . prolonged and sometimes painful erections
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets are white to off - white , round and of a
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : treat the symptoms of primary parkinson ' s disease in adults , in combination with levodopa . parkinson ', s disease is characterised by the symptoms associated with moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sifol . - if your doctor has told you that you have any medical conditions that could increase symptoms of kidney disease . - hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa may cause dyskineia . warnings and actions
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . during the first week , 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg ) will be taken . after 1 week , 2 tablets of sofrol 0. 088mg ( 0. 264 mg ), your doctor may increase your dose to a maximum of one tablet per day depending on your symptoms . the usual starting dose is 1 tablet ( 0 , 088 ml ) of s
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ): common ( might affect up to 1 in 100 people ): uncommon ( may affects up to1 in 1 , 000 people ): very rare ( may effect up to one in 10 , 000 patients ): not known ( frequency cannot be estimated from the available data ): - if you have parkinson ' s disease , tell your doctor straight away if you notice any of the following side effects : - dyskinesia ( e . g .
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , in 0 . 7 ml of solution . the other ingredients are pramipxole 0 . 125 mg , 1 mg , 2 mg , 3 mg , and 1 mg pramiperxole dihydrochloride monohydrate . the ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack sifol
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to prevent allergic conditions from occurring in the eye , and to reduce the allergic reaction . allergic conjustivitis may occur with the use of some materials ( allergens ) that may cause allergic reactions such as itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . do not try to avoid contact with the affected area . if any of the signs of allergic conjugunctivitus occur , contact your doctor straight away . if they do not go
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using emadadine . children and adolescents do not give this medicine to children and teenagers under the age of 3 years because benzalkonium chloride is present in the blood . emadines should not be used in children and adolescent under the ages of 6 . clinical trials have not been performed in children under the influence of emadined . if you have kidney
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 3 drops in each eye . use this tip only once a day . do not use this if your eyes are not clear . how to use step 1 : step 2 : step 1 . hold the emadine bottle with both hands . remove the bottle from the bottle . remove one side of the cap . twist off cap and snap collar . hold it firmly . hold on the bottle with your thumb or finger . tilt your head back . pull down your eyelid with
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects may be reduced by the use of the drops . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneals staining , dry eye . general side effects include headache , difficulty sleeping , sinus headache , bad taste
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains the active substance is emadastine 0 . 5 mg / ml . the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . each bottle contains one single - use syringe .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). leveiracetaman is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). levantiracetamer has been
do not take levetiracetam actavis - if you are allergic to levetiraacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking leveturacetamactavis - tell your doctor if you have kidney problems - tell the doctor if any slow down in the growth or unexpected puberty development of your child has been reported . - if your child is taking anti - epileptics such as levetaracetam actingavis - your child may have thoughts of harming or killing themselves . tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis in the morning and one tablet in the evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet ( 1 , 000 mg ) once daily . the dose may later be increased to 3 , 000 iu ( 1 tablet of half a milliliter ) once a day . your doctor will tell you the dose to take . your dose will be adjusted by your doctor depending on your condition and on how
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ), flu - like symptoms and a rash on the face followed by an extended rash with a high temperature and increased levels of liver enzymes seen in blood tests ( a type of white blood cell ) 56 eosinophilia ( enlarged
what levetiracetam actavis contains the active substance is levetiraacetam . levetaracetamactavis 250 mg : each tablet contains 250 mg of levetiroacetam ( as levetviracetam ). leveturacetam amavis 500 mg : one tablet contains 500 mg of the active ingredient levetvetir acetam (as levetoracetam agavis ). each 750 mg tablet contains 750 mg of of leveiracetamine ( as besilate ). leveriracetarm actavis 1 , 000 mg : the active substances are levetiralacetam , cro
incruse ellipta contains the active substance umeclidinium bromide which belongs to a group of medicines called bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become blocked . this leads to breathing difficulties . incrose elliptea works by reducing the amount of air that gets in and out of the lungs . this helps to control breathing difficulties and reduces the tightening of the muscles in the airway . it also helps to reduce your breathing difficulties when
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : - if your child has asthma . incruruse ellipta should not be used in children with asthma . - if the child has heart problems . - tell your doctor if your baby has an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , a blockage in your bladder ). - if he / she has severe liver problems
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use incruse ellipta every day , with or without food . try to use incrose ellipte at the usual time each morning and evening . if you have symptoms of using this medicine , such as a sudden attack of breathlessness or wheezing , you should seek immediate advice from your doctor . if this attack does not go away , you may need a
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose or throat cough feeling of pressure or pain in the cheeks and forehead . inflammation of the sinuses (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalard should be used within 6 months . once the inhaluer has been opened , the use of the product within 30 . do this once the seal has been removed from the tray . do away
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms umecylidinia . each adult should receive a delivered doses of 65 microgramms umechloridinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrute ellipta is an inhalation powder . the ellipta inhaler is supplied in
nucala contains the active substance mepolizumab , a monoclonal antibody . this type of protein is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type of white blood cell that helps the lungs breathe ) in patients with eosinaophilic asthma . asthma nucala is used in asthma attacks to prevent you from using medicines called high dose inhalers that help control your asthma . these medicines may be medicines called oral corticosteroids . nucal can be used alone or in combination with medicines called me
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 patients have experienced asthma - related side effects when using nucal . if your asthma is not controlled with nucalan , your doctor may decide to reduce the dose or stop nucla treatment . if you think you may be allergic , ask your doctor for advice . injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions to other
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a week . children and adolescents 1 year of age or older : your doctor will decide the dose that is right for you . the pre - filled pen will be used for you to inject nucala . duration of treatment with nucal your doctor may decide to continue the treatment with a lower dose . your doctor should decide how long you should continue to receive nuca . if your asthma symptoms do not improve or attacks occur , your doctor might decide to treat your asthma
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms can be severe . symptoms include chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( this may be a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction or if you notice a similar reaction to nucla . other side
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the nucal pre -filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for a maximum of 7 days in the refrigerator ( 1 to 7 ). do away with the pre pre - fill pen once it has been opened . do away from direct heat
what nucala contains - the active substance is mepolizumab . each 1 ml vial contains 100 mg of mepolizzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale 1 mg is supplied as a pack containing 1 vial or as a multipack containing 3 vials of 1 ml . not all pack sizes may be marketed .
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what ninlara is used for ninlalo is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival . myelomas cells have a lot of proteins called proteasomes , which are involved in the growth and spread of cancer . how ninlhar works ninlero is used in adults to treat multiple myelooma . ninlao is used on its own in combination with lenalidomide
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you : if you have a history of bleeding if you experience persistent nausea , vomiting or diarrhoea if you suffer from nerve problems if you develop tingling , numbness , swelling or a persistent rash if you know that you have liver or kidney problems if any part of your kidney is not working properly tell your doctor before starting treatment with ninlara . before starting
you must not be given ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of ninlar is lenalidomide ( a medicine that works by blocking the action of dexamethasone ), an anti - inflammatory medicine . how often to take ninlara take lenalidome and dexamETHasone once a day for the first 3 weeks . in the first 4 weeks , you will take lenidomide 25 mg once a morning on the same
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash that may become itchy all over the body rare side effects : may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use this medicinal product immediately . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance in each capsule of ninlar 2 . 3 mg is ixazomib . each capsule contains 2 .3 mg ixasomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. the printing ink contains : - the capsule content contains : ixar 3 mg ikazomab ( 3 mg / 4 .
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palfORzia . children and adolescents ( from 4 to 17 years of age ) palfora is not recommended for treatment of peanut allergy due to the risk of peanut ( desensitisation ) in children . palforbzia is not known to cause allergic reactions . poforzinia is not indicated for the treatment of food allergies . if you have any further questions on the use of palfourzia , ask your doctor ,
do not take palforzia - if you are allergic to severe asthma or any of the other ingredients of palfourzia ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking palfurzia : - if your asthma is getting worse or if you have a problem swallowing . - if there are long term problems with your digestive system such as a severe mast cell disorder . - severe or life - threatening anaphylaxis . if this happens within 60 days of starting treatment with palfiorzia , stop taking paforzias and seek medical help
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of allergy if you have allergic reactions ( anaphylaxis ), your doctor may decide to increase your dose to 3 mg once a day . duration of treatment your doctor will prescribe palforzia as initial doseescalation . these treatment steps are given as follows : the initial dose doseescalated and up - dosing steps are shown below . if you take more palfourzia than you should if you accidentally take too many tablets , contact your doctor immediately . if possible ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : severe allergic reactions if you have any of the following symptoms after taking palforfzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting , severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palforsia may cause problems with the stomach and digestive system ( eosinophilic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or particles in the vials . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfoforz . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules with opening microcrycrystallinine celluloses , colloid anhydrated silica , and magnesium unstearate pealforza 300 mg oralpowder in sachet microcry crystalline cellulos , collaborhydrous siliconica and and magnesiumstearate beige oral
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions . zerene is used to treat sleeping problems in adults . it is started by a doctor who is experienced in the use of this type of medicine . it should be used during treatment . it can be used if you have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes very weak and tired muscles , severe breathing and chest problems ) if any of these apply to you , tell your doctor . children and adolescents zeren is not recommended for use in children and teenagers under 18 years of age . therefore , zereNE should not be used in children or adolescents
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , you should take the capsule with you . if your doctor thinks you may be 65 years of age or older , or if you suffer from mild to moderate liver problems , the recommended starting dose is two 5 mg capsules per day . if the capsule is cloudy , you may feel that there is an overdose , or you may become increasingly drowsy or have a coma . if
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare but very rare . very rare cases : very common : may affect less than1 user in 1, 000 not known ( frequency cannot be
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : capsule contents : microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . capsule shell : lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( k29 - 32 ), gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphacy ( e133 ), silicon dioxide . printing ink : shellac , lec
